{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:25:15Z","timestamp":1791721515915,"version":"4.3.4"},"reference-count":282,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373950"],"award-info":[{"award-number":["82373950"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274024"],"award-info":[{"award-number":["82274024"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404749"],"award-info":[{"award-number":["82404749"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404751"],"award-info":[{"award-number":["82404751"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300799"],"award-info":[{"award-number":["82300799"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2023IR06"],"award-info":[{"award-number":["2023IR06"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Liver sinusoidal endothelial cells (LSECs) form a specialized discontinuous microvascular interface between sinusoidal blood and the hepatic parenchyma. Functioning as a central regulator of hepatic homeostasis, LSECs integrate metabolic, inflammatory, and hemodynamic signals to maintain sinusoidal permeability, immune tolerance, vascular tone, and lipid exchange. During acute injury or sustained hepatic stress, LSECs may lose their differentiated sinusoidal phenotype and acquire features of capillarization, including fenestrae loss, subendothelial matrix accumulation, impaired scavenging activity, and attenuation of KLF2-eNOS-NO signaling. Capillarized LSECs are not merely a byproduct of hepatic damage; instead, they may function as early endothelial sentinels and important contributors to the amplification of parenchymal injury, inflammation, fibrogenesis, and tumor immune evasion. This review summarizes the physiological functions of LSECs and examines mechanisms through which LSEC dysfunction contributes to acute liver injury, metabolic dysfunction-associated steatotic liver disease, viral hepatitis, cirrhosis, and hepatocellular carcinoma. By comparing conserved mechanisms with disease-specific spatial and molecular triggers, this review highlights how LSEC phenotypic switching disrupts the angiocrine\u2013immune\u2013fibrotic axis and contributes to disease progression. Recent advances in single-cell and spatial omics, LSEC subpopulation heterogeneity, and capillarization-aware therapeutic delivery are further discussed. Finally, therapeutic reprogramming of dysfunctional LSECs toward a quiescent, fenestrated, and tolerogenic phenotype is proposed as a strategy to restore sinusoidal homeostasis and improve treatment of liver diseases.<\/jats:p>","DOI":"10.1186\/s43556-026-00527-z","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:02:17Z","timestamp":1786939337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Liver sinusoidal endothelial cells in liver diseases and hepatocellular carcinoma: molecular mechanisms, physiology, and therapies"],"prefix":"10.1186","volume":"7","author":[{"given":"Mengyao","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8245-2611","authenticated-orcid":false,"given":"Qian","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"issue":"1","key":"527_CR1","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12964-024-01720-9","volume":"22","author":"Q He","year":"2024","unstructured":"He Q, He W, Dong H, Guo Y, Yuan G, Shi X, et al. Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease. Cell Commun Signal. 2024;22(1):346. https:\/\/doi.org\/10.1186\/s12964-024-01720-9.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"527_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3350\/cmh.2024.0022","volume":"30","author":"J Qu","year":"2024","unstructured":"Qu J, Wang L, Li Y, Li X. Liver sinusoidal endothelial cell: an important yet often overlooked player in the liver fibrosis. Clin Mol Hepatol. 2024;30(3):303\u201325. https:\/\/doi.org\/10.3350\/cmh.2024.0022.","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"527_CR3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/ph18060893","volume":"18","author":"J Zhou","year":"2025","unstructured":"Zhou J, Wang J, Zhang L, Zhang C, Tian C. Defenestration of liver sinusoidal endothelial cells: the trigger of liver fibrosis. Pharmaceuticals (Basel). 2025;18(6):893. https:\/\/doi.org\/10.3390\/ph18060893.","journal-title":"Pharmaceuticals (Basel)"},{"key":"527_CR4","doi-asserted-by":"publisher","first-page":"1497788","DOI":"10.3389\/fimmu.2024.1497788","volume":"15","author":"KN Kremer","year":"2025","unstructured":"Kremer KN, Khammash HA, Miranda AM, Rutt LN, Twardy SM, Anton PE, et al. Liver sinusoidal endothelial cells regulate the balance between hepatic immunosuppression and immunosurveillance. Front Immunol. 2025;15:1497788. https:\/\/doi.org\/10.3389\/fimmu.2024.1497788.","journal-title":"Front Immunol"},{"key":"527_CR5","doi-asserted-by":"publisher","first-page":"1542380","DOI":"10.3389\/fimmu.2025.1542380","volume":"16","author":"SH Wang","year":"2025","unstructured":"Wang SH, Serr I, Digigow R, Metzler B, Surnov A, Gottwick C, et al. Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models. Front Immunol. 2025;16:1542380. https:\/\/doi.org\/10.3389\/fimmu.2025.1542380.","journal-title":"Front Immunol"},{"key":"527_CR6","doi-asserted-by":"publisher","first-page":"1834595","DOI":"10.3389\/fimmu.2026.1834595","volume":"17","author":"C Gottwick","year":"2026","unstructured":"Gottwick C, Averhoff P, Casar C, Liebig LA, Pilz SM, Haas V, et al. Antigen-specific tolerance and control of autoimmunity effected by liver sinusoidal endothelial cells is unimpaired in liver fibrosis. Front Immunol. 2026;17:1834595. https:\/\/doi.org\/10.3389\/fimmu.2026.1834595.","journal-title":"Front Immunol"},{"issue":"5","key":"527_CR7","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3390\/jcm13051406","volume":"13","author":"I Minciuna","year":"2024","unstructured":"Minciuna I, Taru MG, Procopet B, Stefanescu H. The interplay between liver sinusoidal endothelial cells, platelets, and neutrophil extracellular traps in the development and progression of metabolic dysfunction-associated steatotic liver disease. J Clin Med. 2024;13(5):1406. https:\/\/doi.org\/10.3390\/jcm13051406.","journal-title":"J Clin Med"},{"issue":"8","key":"527_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000513","volume":"8","author":"M Yu","year":"2024","unstructured":"Yu M, Li X, Xu L, Zheng C, Pan W, Chen H, et al. Neutrophil extracellular traps induce intrahepatic thrombotic tendency and liver damage in cholestatic liver disease. Hepatol Commun. 2024;8(8):e0513. https:\/\/doi.org\/10.1097\/HC9.0000000000000513.","journal-title":"Hepatol Commun"},{"issue":"5","key":"527_CR9","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3390\/cells9051243","volume":"9","author":"J Meyer","year":"2020","unstructured":"Meyer J, Balaphas A, Fontana P, Morel P, Robson SC, Sadoul K, et al. Platelet interactions with liver sinusoidal endothelial cells and hepatic stellate cells lead to hepatocyte proliferation. Cells. 2020;9(5):1243. https:\/\/doi.org\/10.3390\/cells9051243.","journal-title":"Cells"},{"issue":"2","key":"527_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jhep.2020.08.033","volume":"74","author":"M Winkler","year":"2021","unstructured":"Winkler M, Staniczek T, Kurschner SW, Schmid CD, Schonhaber H, Cordero J, et al. Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling. J Hepatol. 2021;74(2):380\u201393. https:\/\/doi.org\/10.1016\/j.jhep.2020.08.033.","journal-title":"J Hepatol"},{"issue":"2","key":"527_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/hep.30232","volume":"69","author":"B Zapotoczny","year":"2019","unstructured":"Zapotoczny B, Szafranska K, Kus E, Braet F, Wisse E, Chlopicki S, et al. Tracking fenestrae dynamics in live murine liver sinusoidal endothelial cells. Hepatology. 2019;69(2):876\u201388. https:\/\/doi.org\/10.1002\/hep.30232.","journal-title":"Hepatology"},{"issue":"1","key":"527_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41392-023-01621-2","volume":"8","author":"ZW Li","year":"2023","unstructured":"Li ZW, Ruan B, Yang PJ, Liu JJ, Song P, Duan JL, et al. Oit3, a promising hallmark gene for targeting liver sinusoidal endothelial cells. Signal Transduct Target Ther. 2023;8(1):344. https:\/\/doi.org\/10.1038\/s41392-023-01621-2.","journal-title":"Signal Transduct Target Ther"},{"key":"527_CR13","doi-asserted-by":"publisher","first-page":"1576739","DOI":"10.3389\/fimmu.2025.1576739","volume":"16","author":"T Yang","year":"2025","unstructured":"Yang T, Gu Z, Feng J, Shan J, Qian C, Zhuang N. Non-parenchymal cells: key targets for modulating chronic liver diseases. Front Immunol. 2025;16:1576739. https:\/\/doi.org\/10.3389\/fimmu.2025.1576739.","journal-title":"Front Immunol"},{"issue":"8","key":"527_CR14","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.4049\/jimmunol.0902580","volume":"184","author":"A Schurich","year":"2010","unstructured":"Schurich A, Berg M, Stabenow D, B\u00f6ttcher J, Kern M, Schild HJ, et al. Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells. J Immunol. 2010;184(8):4107\u201314. https:\/\/doi.org\/10.4049\/jimmunol.0902580.","journal-title":"J Immunol"},{"issue":"3","key":"527_CR15","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s44319-025-00673-5","volume":"27","author":"G Zurawska","year":"2026","unstructured":"Zurawska G, Sas Z, Jonczy A, Mahadeva R, Slusarczyk P, Chwalek M, et al. Liver sinusoidal endothelial cells constitute a major route for hemoglobin clearance. EMBO Rep. 2026;27(3):598\u2013628. https:\/\/doi.org\/10.1038\/s44319-025-00673-5.","journal-title":"EMBO Rep"},{"issue":"6169","key":"527_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1126\/science.1244880","volume":"343","author":"J Hu","year":"2014","unstructured":"Hu J, Srivastava K, Wieland M, Runge A, Mogler C, Besemfelder E, et al. Endothelial cell-derived angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat. Science. 2014;343(6169):416\u20139. https:\/\/doi.org\/10.1126\/science.1244880.","journal-title":"Science"},{"issue":"2","key":"527_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jhep.2026.03.022","volume":"85","author":"R Manco","year":"2026","unstructured":"Manco R, Moliterni C, Neirynck G, Claus R, De Rudder M, Picalausa C, et al. Liver sinusoidal endothelial cells and laminin dictate cholangiocytes\u2019 fate in chronic liver disease. J Hepatol. 2026;85(2):257\u201370. https:\/\/doi.org\/10.1016\/j.jhep.2026.03.022.","journal-title":"J Hepatol"},{"issue":"9","key":"527_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26093988","volume":"26","author":"M Puri","year":"2025","unstructured":"Puri M, Sonawane S. Liver sinusoidal endothelial cells in the regulation of immune responses and fibrosis in metabolic dysfunction-associated fatty liver disease. Int J Mol Sci. 2025;26(9):3988. https:\/\/doi.org\/10.3390\/ijms26093988.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"527_CR19","doi-asserted-by":"publisher","first-page":"101784","DOI":"10.1016\/j.jhepr.2026.101784","volume":"8","author":"Z Yang","year":"2026","unstructured":"Yang Z, Li QT, Yue ZS, Li ZW, Zou P, Ling YW, et al. Liver sinusoidal endothelial TGF-beta signaling accelerates partial endothelial-mesenchymal transition and MASH through Notch. JHEP Rep. 2026;8(4):101784. https:\/\/doi.org\/10.1016\/j.jhepr.2026.101784.","journal-title":"JHEP Rep"},{"key":"527_CR20","doi-asserted-by":"publisher","first-page":"936196","DOI":"10.3389\/fimmu.2022.936196","volume":"13","author":"W Du","year":"2022","unstructured":"Du W, Wang L. The crosstalk between liver sinusoidal endothelial cells and hepatic microenvironment in NASH related liver fibrosis. Front Immunol. 2022;13:936196. https:\/\/doi.org\/10.3389\/fimmu.2022.936196.","journal-title":"Front Immunol"},{"issue":"11","key":"527_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04966-7","volume":"80","author":"RI Velliou","year":"2023","unstructured":"Velliou RI, Legaki AI, Nikolakopoulou P, Vlachogiannis NI, Chatzigeorgiou A. Liver endothelial cells in NAFLD and transition to NASH and HCC. Cell Mol Life Sci. 2023;80(11):314. https:\/\/doi.org\/10.1007\/s00018-023-04966-7.","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"527_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41575-018-0020-y","volume":"15","author":"S Shetty","year":"2018","unstructured":"Shetty S, Lalor PF, Adams DH. Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity. Nat Rev Gastroenterol Hepatol. 2018;15(9):555\u201367. https:\/\/doi.org\/10.1038\/s41575-018-0020-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"527_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/HEP.0000000000000207","volume":"78","author":"MJ McConnell","year":"2023","unstructured":"McConnell MJ, Kostallari E, Ibrahim SH, Iwakiri Y. The evolving role of liver sinusoidal endothelial cells in liver health and disease. Hepatology. 2023;78(2):649\u201369. https:\/\/doi.org\/10.1097\/HEP.0000000000000207.","journal-title":"Hepatology"},{"issue":"1","key":"527_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","volume":"66","author":"J Poisson","year":"2017","unstructured":"Poisson J, Lemoinne S, Boulanger C, Durand F, Moreau R, Valla D, et al. Liver sinusoidal endothelial cells: physiology and role in liver diseases. J Hepatol. 2017;66(1):212\u201327. https:\/\/doi.org\/10.1016\/j.jhep.2016.07.009.","journal-title":"J Hepatol"},{"issue":"4","key":"527_CR25","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jcmgh.2020.12.007","volume":"11","author":"T Su","year":"2021","unstructured":"Su T, Yang Y, Lai S, Jeong J, Jung Y, McConnell M, et al. Single-cell transcriptomics reveals zone-specific alterations of liver sinusoidal endothelial cells in cirrhosis. Cell Mol Gastroenterol Hepatol. 2021;11(4):1139\u201361. https:\/\/doi.org\/10.1016\/j.jcmgh.2020.12.007.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"527_CR26","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/cphy.c140078","volume":"5","author":"KK S\u00f8rensen","year":"2015","unstructured":"S\u00f8rensen KK, Simon-Santamaria J, McCuskey RS, Smedsr\u00f8d B. Liver sinusoidal endothelial cells. Compr Physiol. 2015;5(4):1751\u201374. https:\/\/doi.org\/10.1002\/cphy.c140078.","journal-title":"Compr Physiol"},{"issue":"1","key":"527_CR27","doi-asserted-by":"publisher","first-page":"G71","DOI":"10.1152\/ajpgi.00215.2010","volume":"300","author":"R Li","year":"2011","unstructured":"Li R, Oteiza A, Sorensen KK, McCourt P, Olsen R, Smedsrod B, et al. Role of liver sinusoidal endothelial cells and stabilins in elimination of oxidized low-density lipoproteins. Am J Physiol Gastrointest Liver Physiol. 2011;300(1):G71\u201381. https:\/\/doi.org\/10.1152\/ajpgi.00215.2010.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"527_CR28","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jhep.2019.02.012","volume":"70","author":"A Hammoutene","year":"2019","unstructured":"Hammoutene A, Rautou PE. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. J Hepatol. 2019;70(6):1278\u201391. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.012.","journal-title":"J Hepatol"},{"issue":"10","key":"527_CR29","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/labinvest.2015.95","volume":"95","author":"M Miyao","year":"2015","unstructured":"Miyao M, Kotani H, Ishida T, Kawai C, Manabe S, Abiru H, et al. Pivotal role of liver sinusoidal endothelial cells in NAFLD\/NASH progression. Lab Invest. 2015;95(10):1130\u201344. https:\/\/doi.org\/10.1038\/labinvest.2015.95.","journal-title":"Lab Invest"},{"issue":"3","key":"527_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jhep.2022.03.029","volume":"77","author":"T Greuter","year":"2022","unstructured":"Greuter T, Yaqoob U, Gan C, Jalan-Sakrikar N, Kostallari E, Lu J, et al. Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo. J Hepatol. 2022;77(3):723\u201334. https:\/\/doi.org\/10.1016\/j.jhep.2022.03.029.","journal-title":"J Hepatol"},{"issue":"11","key":"527_CR31","doi-asserted-by":"publisher","first-page":"e2003721","DOI":"10.1002\/advs.202003721","volume":"8","author":"X Wu","year":"2021","unstructured":"Wu X, Shu L, Zhang Z, Li J, Zong J, Cheong LY, et al. Adipocyte fatty acid binding protein promotes the onset and progression of liver fibrosis via mediating the crosstalk between liver sinusoidal endothelial cells and hepatic stellate cells. Adv Sci (Weinh). 2021;8(11):e2003721. https:\/\/doi.org\/10.1002\/advs.202003721.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"527_CR32","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jhep.2024.05.014","volume":"81","author":"J Gao","year":"2024","unstructured":"Gao J, Lan T, Kostallari E, Guo Y, Lai E, Guillot A, et al. Angiocrine signaling in sinusoidal homeostasis and liver diseases. J Hepatol. 2024;81(3):543\u201361. https:\/\/doi.org\/10.1016\/j.jhep.2024.05.014.","journal-title":"J Hepatol"},{"issue":"4","key":"527_CR33","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/hep.30655","volume":"70","author":"A Desroches-Castan","year":"2019","unstructured":"Desroches-Castan A, Tillet E, Ricard N, Ouarne M, Mallet C, Belmudes L, et al. Bone morphogenetic protein 9 is a paracrine factor controlling liver sinusoidal endothelial cell fenestration and protecting against hepatic fibrosis. Hepatology. 2019;70(4):1392\u2013408. https:\/\/doi.org\/10.1002\/hep.30655.","journal-title":"Hepatology"},{"issue":"14","key":"527_CR34","doi-asserted-by":"publisher","first-page":"e05055","DOI":"10.1002\/adhm.202505055","volume":"15","author":"JB Zhao","year":"2026","unstructured":"Zhao JB, Luo GQ, Wu ZH, Lin JY, Zhang CH, Wu GB, et al. Spermidine-based carbon quantum dots alleviate liver sinusoidal endothelial dysfunction by inducing LSEC-derived NO to ameliorate hepatic fibrosis and portal hypertension. Adv Healthc Mater. 2026;15(14):e05055. https:\/\/doi.org\/10.1002\/adhm.202505055.","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"527_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","volume":"18","author":"J Gracia-Sancho","year":"2021","unstructured":"Gracia-Sancho J, Caparros E, Fernandez-Iglesias A, Frances R. Role of liver sinusoidal endothelial cells in liver diseases. Nat Rev Gastroenterol Hepatol. 2021;18(6):411\u201331. https:\/\/doi.org\/10.1038\/s41575-020-00411-3.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7481","key":"527_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12681","volume":"505","author":"BS Ding","year":"2014","unstructured":"Ding BS, Cao Z, Lis R, Nolan DJ, Guo P, Simons M, et al. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature. 2014;505(7481):97\u2013102. https:\/\/doi.org\/10.1038\/nature12681.","journal-title":"Nature"},{"issue":"3","key":"527_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3892\/mmr.2024.13164","volume":"29","author":"J Gao","year":"2024","unstructured":"Gao J, Zuo B, He Y. Liver sinusoidal endothelial cells as potential drivers of liver fibrosis (review). Mol Med Rep. 2024;29(3):40. https:\/\/doi.org\/10.3892\/mmr.2024.13164.","journal-title":"Mol Med Rep"},{"issue":"8","key":"527_CR38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41575-020-0304-x","volume":"17","author":"P Ramachandran","year":"2020","unstructured":"Ramachandran P, Matchett KP, Dobie R, Wilson-Kanamori JR, Henderson NC. Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis. Nat Rev Gastroenterol Hepatol. 2020;17(8):457\u201372. https:\/\/doi.org\/10.1038\/s41575-020-0304-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"527_CR39","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jhep.2025.10.017","volume":"84","author":"E Felli","year":"2026","unstructured":"Felli E, Nulan Y, Ortega-Ribera M, Fernandez-Iglesias A, Gracia-Sancho J. The role of liver sinusoidal endothelial cells in liver diseases: key players in health and pathology. J Hepatol. 2026;84(3):655\u201372. https:\/\/doi.org\/10.1016\/j.jhep.2025.10.017.","journal-title":"J Hepatol"},{"issue":"7783","key":"527_CR40","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran P, Dobie R, Wilson-Kanamori JR, Dora EF, Henderson BEP, Luu NT, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575(7783):512\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1631-3.","journal-title":"Nature"},{"issue":"1","key":"527_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13578-024-01215-7","volume":"14","author":"HY Li","year":"2024","unstructured":"Li HY, Gao YX, Wu JC, Li JZ, Fu SW, Xu MY. Single-cell transcriptome reveals a novel mechanism of c-Kit(+)-liver sinusoidal endothelial cells in NASH. Cell Biosci. 2024;14(1):31. https:\/\/doi.org\/10.1186\/s13578-024-01215-7.","journal-title":"Cell Biosci"},{"issue":"21","key":"527_CR42","doi-asserted-by":"publisher","first-page":"10701","DOI":"10.3390\/ijms262110701","volume":"26","author":"E Paolini","year":"2025","unstructured":"Paolini E, Longo M, Meroni M, Dongiovanni P. Hepatic zonation in MASLD: old question, new challenge in the era of spatial omics. Int J Mol Sci. 2025;26(21):10701. https:\/\/doi.org\/10.3390\/ijms262110701.","journal-title":"Int J Mol Sci"},{"key":"527_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-337143","author":"G Chen","year":"2026","unstructured":"Chen G, Dai W, Wang J, Shen Z, Guo Y, Ge Q, et al. Endothelial RAP1A attenuates sinusoidal capillarisation and liver fibrosis by inhibiting RAF1-mediated Notch activation. Gut. 2026. https:\/\/doi.org\/10.1136\/gutjnl-2025-337143.","journal-title":"Gut"},{"issue":"7","key":"527_CR44","doi-asserted-by":"publisher","first-page":"167964","DOI":"10.1016\/j.bbadis.2025.167964","volume":"1871","author":"SW Fu","year":"2025","unstructured":"Fu SW, Gao YX, Li HY, Wu JC, Li ZH, Xu MY. The ameliorative effect of C-Kit+ hepatic endothelial cells with Mertk deficiency on nonalcoholic steatohepatitis. Biochim Biophys Acta Mol Basis Dis. 2025;1871(7):167964. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167964.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"527_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jhep.2015.01.036","volume":"63","author":"P Kocabayoglu","year":"2015","unstructured":"Kocabayoglu P, Lade A, Lee YA, Dragomir AC, Sun X, Fiel MI, et al. \u03b2-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis. J Hepatol. 2015;63(1):141\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2015.01.036.","journal-title":"J Hepatol"},{"issue":"6","key":"527_CR46","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/j.1478-3231.2012.02806.x","volume":"32","author":"Y Kim","year":"2012","unstructured":"Kim Y, Fiel MI, Albanis E, Chou HI, Zhang W, Khitrov G, et al. Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate. Liver Int. 2012;32(6):1008\u201317. https:\/\/doi.org\/10.1111\/j.1478-3231.2012.02806.x.","journal-title":"Liver Int"},{"issue":"2","key":"527_CR47","doi-asserted-by":"publisher","first-page":"116915","DOI":"10.1016\/j.celrep.2025.116915","volume":"45","author":"K Li","year":"2026","unstructured":"Li K, Kumar V, To T, Gonzalez-Dominguez A, Huria J, Yu M, et al. Scar-associated endothelial-stellate cellular crosstalk drives fibrosis resolution in MASH. Cell Rep. 2026;45(2):116915. https:\/\/doi.org\/10.1016\/j.celrep.2025.116915.","journal-title":"Cell Rep"},{"issue":"10","key":"527_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107966","volume":"26","author":"AL Wilkinson","year":"2023","unstructured":"Wilkinson AL, Hulme S, Kennedy JI, Mann ER, Horn P, Shepherd EL, et al. The senescent secretome drives PLVAP expression in cultured human hepatic endothelial cells to promote monocyte transmigration. iScience. 2023;26(10):107966. https:\/\/doi.org\/10.1016\/j.isci.2023.107966.","journal-title":"iScience"},{"issue":"4","key":"527_CR49","doi-asserted-by":"publisher","first-page":"G803","DOI":"10.1152\/ajpgi.00215.2019","volume":"318","author":"W de Haan","year":"2020","unstructured":"de Haan W, Oie C, Benkheil M, Dheedene W, Vinckier S, Coppiello G, et al. Unraveling the transcriptional determinants of liver sinusoidal endothelial cell specialization. Am J Physiol Gastrointest Liver Physiol. 2020;318(4):G803\u201315. https:\/\/doi.org\/10.1152\/ajpgi.00215.2019.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"527_CR50","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/gut.2010.220913","volume":"60","author":"J Gracia-Sancho","year":"2011","unstructured":"Gracia-Sancho J, Russo L, Garcia-Caldero H, Garcia-Pagan JC, Garcia-Cardena G, Bosch J. Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver. Gut. 2011;60(4):517\u201324. https:\/\/doi.org\/10.1136\/gut.2010.220913.","journal-title":"Gut"},{"issue":"4","key":"527_CR51","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.stem.2022.03.002","volume":"29","author":"JM Gomez-Salinero","year":"2022","unstructured":"Gomez-Salinero JM, Izzo F, Lin Y, Houghton S, Itkin T, Geng F, et al. Specification of fetal liver endothelial progenitors to functional zonated adult sinusoids requires c-Maf induction. Cell Stem Cell. 2022;29(4):593-609.e7. https:\/\/doi.org\/10.1016\/j.stem.2022.03.002.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"527_CR52","doi-asserted-by":"publisher","first-page":"e230026","DOI":"10.1530\/JME-23-0026","volume":"71","author":"D Nagy","year":"2023","unstructured":"Nagy D, Maude H, Birdsey GM, Randi AM, Cebola I. RISING STARS: liver sinusoidal endothelial transcription factors in metabolic homeostasis and disease. J Mol Endocrinol. 2023;71(2):e230026. https:\/\/doi.org\/10.1530\/JME-23-0026.","journal-title":"J Mol Endocrinol"},{"issue":"29","key":"527_CR53","doi-asserted-by":"publisher","first-page":"26729","DOI":"10.18632\/oncotarget.4925","volume":"6","author":"A El Taghdouini","year":"2015","unstructured":"El Taghdouini A, Sorensen AL, Reiner AH, Coll M, Verhulst S, Mannaerts I, et al. Genome-wide analysis of DNA methylation and gene expression patterns in purified, uncultured human liver cells and activated hepatic stellate cells. Oncotarget. 2015;6(29):26729\u201345. https:\/\/doi.org\/10.18632\/oncotarget.4925.","journal-title":"Oncotarget"},{"issue":"1","key":"527_CR54","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12916-022-02523-w","volume":"20","author":"T Chen","year":"2022","unstructured":"Chen T, Shi Z, Zhao Y, Meng X, Zhao S, Zheng L, et al. LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway. BMC Med. 2022;20(1):335. https:\/\/doi.org\/10.1186\/s12916-022-02523-w.","journal-title":"BMC Med"},{"issue":"5","key":"527_CR55","doi-asserted-by":"publisher","first-page":"e0700","DOI":"10.1097\/HC9.0000000000000700","volume":"9","author":"L Abad-Jorda","year":"2025","unstructured":"Abad-Jorda L, Martinez-Alcocer A, Guixe-Muntet S, Hunt NJ, Westwood LJ, Lozano JJ, et al. miR-27b-3p modulates liver sinusoidal endothelium dedifferentiation in chronic liver disease. Hepatol Commun. 2025;9(5):e0700. https:\/\/doi.org\/10.1097\/HC9.0000000000000700.","journal-title":"Hepatol Commun"},{"issue":"3","key":"527_CR56","doi-asserted-by":"publisher","first-page":"G344","DOI":"10.1152\/ajpgi.00081.2021","volume":"321","author":"L Yang","year":"2021","unstructured":"Yang L, Xu X, Chen Z, Zhang Y, Chen H, Wang X. MiR-511-3p promotes hepatic sinusoidal obstruction syndrome by activating hedgehog pathway via targeting Ptch1. Am J Physiol Gastrointest Liver Physiol. 2021;321(3):G344\u201354. https:\/\/doi.org\/10.1152\/ajpgi.00081.2021.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"527_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s44355-024-00007-7","volume":"1","author":"SE Selicean","year":"2024","unstructured":"Selicean SE, Felli E, Wang C, Nulan Y, Lozano JJ, Guixe-Muntet S, et al. Stiffness-induced modulation of ERG transcription factor in chronic liver disease. NPJ Gut Liver. 2024;1(1):7. https:\/\/doi.org\/10.1038\/s44355-024-00007-7.","journal-title":"NPJ Gut Liver"},{"issue":"6736","key":"527_CR58","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/21224","volume":"399","author":"S Dimmeler","year":"1999","unstructured":"Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399(6736):601\u20135. https:\/\/doi.org\/10.1038\/21224.","journal-title":"Nature"},{"issue":"6736","key":"527_CR59","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/21218","volume":"399","author":"D Fulton","year":"1999","unstructured":"Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999;399(6736):597\u2013601. https:\/\/doi.org\/10.1038\/21218.","journal-title":"Nature"},{"issue":"8","key":"527_CR60","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/CIRCRESAHA.107.165530","volume":"102","author":"L David","year":"2008","unstructured":"David L, Mallet C, Keramidas M, Lamande N, Gasc JM, Dupuis-Girod S, et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res. 2008;102(8):914\u201322. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.165530.","journal-title":"Circ Res"},{"issue":"2","key":"527_CR61","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/hep.29834","volume":"68","author":"JL Duan","year":"2018","unstructured":"Duan JL, Ruan B, Yan XC, Liang L, Song P, Yang ZY, et al. Endothelial Notch activation reshapes the angiocrine of sinusoidal endothelia to aggravate liver fibrosis and blunt regeneration in mice. Hepatology. 2018;68(2):677\u201390. https:\/\/doi.org\/10.1002\/hep.29834.","journal-title":"Hepatology"},{"issue":"1","key":"527_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s11658-024-00584-8","volume":"29","author":"P Kaczara","year":"2024","unstructured":"Kaczara P, Czyzynska-Cichon I, Kus E, Kurpinska A, Olkowicz M, Wojnar-Lason K, et al. Liver sinusoidal endothelial cells rely on oxidative phosphorylation but avoid processing long-chain fatty acids in their mitochondria. Cell Mol Biol Lett. 2024;29(1):67. https:\/\/doi.org\/10.1186\/s11658-024-00584-8.","journal-title":"Cell Mol Biol Lett"},{"issue":"4","key":"527_CR63","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1053\/j.gastro.2011.12.017","volume":"142","author":"G Xie","year":"2012","unstructured":"Xie G, Wang X, Wang L, Wang L, Atkinson RD, Kanel GC, et al. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. Gastroenterology. 2012;142(4):918-927.e6. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.017.","journal-title":"Gastroenterology"},{"key":"527_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151881","volume":"766","author":"T Chen","year":"2025","unstructured":"Chen T, Zhang H, Shan W, Zhou J, You Y. Liver sinusoidal endothelial cells in hepatic fibrosis: opportunities for future strategies. Biochem Biophys Res Commun. 2025;766:151881. https:\/\/doi.org\/10.1016\/j.bbrc.2025.151881.","journal-title":"Biochem Biophys Res Commun"},{"key":"527_CR65","doi-asserted-by":"publisher","first-page":"1171317","DOI":"10.3389\/fcell.2023.1171317","volume":"11","author":"Y Ito","year":"2023","unstructured":"Ito Y, Hosono K, Amano H. Responses of hepatic sinusoidal cells to liver ischemia-reperfusion injury. Front Cell Dev Biol. 2023;11:1171317. https:\/\/doi.org\/10.3389\/fcell.2023.1171317.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"527_CR66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/hep.32787","volume":"78","author":"M Biagioli","year":"2023","unstructured":"Biagioli M, Marchiano S, di Giorgio C, Roselli R, Bordoni M, Bellini R, et al. Combinatorial targeting of g-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury. Hepatology. 2023;78(1):26\u201344. https:\/\/doi.org\/10.1002\/hep.32787.","journal-title":"Hepatology"},{"issue":"16","key":"527_CR67","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.3390\/cells11162511","volume":"11","author":"N Nasiri-Ansari","year":"2022","unstructured":"Nasiri-Ansari N, Androutsakos T, Flessa CM, Kyrou I, Siasos G, Randeva HS, et al. Endothelial cell dysfunction and nonalcoholic fatty liver disease (NAFLD): a concise review. Cells. 2022;11(16):2511. https:\/\/doi.org\/10.3390\/cells11162511.","journal-title":"Cells"},{"issue":"2","key":"527_CR68","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jhep.2021.02.028","volume":"75","author":"Y Yang","year":"2021","unstructured":"Yang Y, Sangwung P, Kondo R, Jung Y, McConnell MJ, Jeong J, et al. Alcohol-induced Hsp90 acetylation is a novel driver of liver sinusoidal endothelial dysfunction and alcohol-related liver disease. J Hepatol. 2021;75(2):377\u201386. https:\/\/doi.org\/10.1016\/j.jhep.2021.02.028.","journal-title":"J Hepatol"},{"key":"527_CR69","doi-asserted-by":"publisher","first-page":"797915","DOI":"10.3389\/fcimb.2022.797915","volume":"12","author":"X Xie","year":"2022","unstructured":"Xie X, Luo J, Zhu D, Zhou W, Yang X, Feng X, et al. HBeAg is indispensable for inducing liver sinusoidal endothelial cell activation by hepatitis B virus. Front Cell Infect Microbiol. 2022;12:797915. https:\/\/doi.org\/10.3389\/fcimb.2022.797915.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"527_CR70","doi-asserted-by":"publisher","first-page":"8760","DOI":"10.1038\/s41598-019-45114-1","volume":"9","author":"A Baiocchini","year":"2019","unstructured":"Baiocchini A, Del Nonno F, Taibi C, Visco-Comandini U, D\u2019Offizi G, Piacentini M, et al. Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C. Sci Rep. 2019;9(1):8760. https:\/\/doi.org\/10.1038\/s41598-019-45114-1.","journal-title":"Sci Rep"},{"issue":"6","key":"527_CR71","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jcmgh.2023.03.003","volume":"15","author":"J Liu","year":"2023","unstructured":"Liu J, Man K. Mechanistic insight and clinical implications of Ischemia\/Reperfusion injury post liver transplantation. Cell Mol Gastroenterol Hepatol. 2023;15(6):1463\u201374. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.03.003.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"527_CR72","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/med.21917","volume":"42","author":"DQ Chen","year":"2022","unstructured":"Chen DQ, Guo Y, Li X, Zhang GQ, Li P. Small molecules as modulators of regulated cell death against ischemia\/reperfusion injury. Med Res Rev. 2022;42(6):2067\u2013101. https:\/\/doi.org\/10.1002\/med.21917.","journal-title":"Med Res Rev"},{"issue":"4","key":"527_CR73","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/hep.20157","volume":"39","author":"PM Huet","year":"2004","unstructured":"Huet PM, Nagaoka MR, Desbiens G, Tarrab E, Brault A, Bralet MP, et al. Sinusoidal endothelial cell and hepatocyte death following cold ischemia-warm reperfusion of the rat liver. Hepatology. 2004;39(4):1110\u20139. https:\/\/doi.org\/10.1002\/hep.20157.","journal-title":"Hepatology"},{"issue":"5","key":"527_CR74","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/hep.31179","volume":"72","author":"X Wang","year":"2020","unstructured":"Wang X, Walkey CJ, Maretti-Mira AC, Wang L, Johnson DL, DeLeve LD. Susceptibility of rat steatotic liver to ischemia-reperfusion is treatable with liver-selective matrix metalloproteinase inhibition. Hepatology. 2020;72(5):1771\u201385. https:\/\/doi.org\/10.1002\/hep.31179.","journal-title":"Hepatology"},{"issue":"1","key":"527_CR75","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jhep.2016.07.051","volume":"66","author":"S Guixe-Muntet","year":"2017","unstructured":"Guixe-Muntet S, de Mesquita FC, Vila S, Hernandez-Gea V, Peralta C, Garcia-Pagan JC, et al. Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injury. J Hepatol. 2017;66(1):86\u201394. https:\/\/doi.org\/10.1016\/j.jhep.2016.07.051.","journal-title":"J Hepatol"},{"issue":"5","key":"527_CR76","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jhep.2013.06.017","volume":"59","author":"C Peralta","year":"2013","unstructured":"Peralta C, Jimenez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol. 2013;59(5):1094\u2013106. https:\/\/doi.org\/10.1016\/j.jhep.2013.06.017.","journal-title":"J Hepatol"},{"issue":"21","key":"527_CR77","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.3390\/cells12212514","volume":"12","author":"Y Yoon","year":"2023","unstructured":"Yoon Y, Gong SC, Kim MY, Baik SK, Hong JE, Rhee KJ, et al. Generation of fibrotic liver organoids using hepatocytes, primary liver sinusoidal endothelial cells, hepatic stellate cells, and macrophages. Cells. 2023;12(21):2514. https:\/\/doi.org\/10.3390\/cells12212514.","journal-title":"Cells"},{"issue":"1","key":"527_CR78","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1053\/j.gastro.2019.03.013","volume":"157","author":"MB Hilscher","year":"2019","unstructured":"Hilscher MB, Sehrawat T, Arab JP, Zeng Z, Gao J, Liu M, et al. Mechanical stretch increases expression of CXCL1 in liver sinusoidal endothelial cells to recruit neutrophils, generate sinusoidal microthombi, and promote portal hypertension. Gastroenterology. 2019;157(1):193-209.e9. https:\/\/doi.org\/10.1053\/j.gastro.2019.03.013.","journal-title":"Gastroenterology"},{"issue":"1","key":"527_CR79","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.apsb.2021.07.021","volume":"12","author":"K Byrnes","year":"2022","unstructured":"Byrnes K, Blessinger S, Bailey NT, Scaife R, Liu G, Khambu B. Therapeutic regulation of autophagy in hepatic metabolism. Acta Pharm Sin B. 2022;12(1):33\u201349. https:\/\/doi.org\/10.1016\/j.apsb.2021.07.021.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"527_CR80","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/gerona\/glz012","volume":"75","author":"D Hide","year":"2020","unstructured":"Hide D, Warren A, Fernandez-Iglesias A, Maeso-Diaz R, Peralta C, Le Couteur DG, et al. Ischemia\/Reperfusion injury in the aged liver: the importance of the sinusoidal endothelium in developing therapeutic strategies for the elderly. J Gerontol A Biol Sci Med Sci. 2020;75(2):268\u201377. https:\/\/doi.org\/10.1093\/gerona\/glz012.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"527_CR81","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/TP.0000000000002028","volume":"102","author":"S Qu","year":"2018","unstructured":"Qu S, Yuan B, Zhang H, Huang H, Zeng Z, Yang S, et al. Heme oxygenase 1 attenuates hypoxia-reoxygenation injury in mice liver sinusoidal endothelial cells. Transplantation. 2018;102(3):426\u201332. https:\/\/doi.org\/10.1097\/TP.0000000000002028.","journal-title":"Transplantation"},{"issue":"2","key":"527_CR82","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.stem.2020.06.007","volume":"27","author":"BK Gage","year":"2020","unstructured":"Gage BK, Liu JC, Innes BT, MacParland SA, McGilvray ID, Bader GD, et al. Generation of functional liver sinusoidal endothelial cells from human pluripotent stem-cell-derived venous angioblasts. Cell Stem Cell. 2020;27(2):254-269.e9. https:\/\/doi.org\/10.1016\/j.stem.2020.06.007.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"527_CR83","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1096\/fj.06-7451com","volume":"21","author":"S Batkai","year":"2007","unstructured":"Batkai S, Osei-Hyiaman D, Pan H, El-Assal O, Rajesh M, Mukhopadhyay P, et al. Cannabinoid-2 receptor mediates protection against hepatic ischemia\/reperfusion injury. FASEB J. 2007;21(8):1788\u2013800. https:\/\/doi.org\/10.1096\/fj.06-7451com.","journal-title":"FASEB J"},{"issue":"1","key":"527_CR84","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/TP.0000000000002098","volume":"103","author":"MB Jimenez-Castro","year":"2019","unstructured":"Jimenez-Castro MB, Casillas-Ramirez A, Negrete-Sanchez E, Avalos-de Leon CG, Gracia-Sancho J, Peralta C. Adipocytokines in steatotic liver Surgery\/Transplantation. Transplantation. 2019;103(1):71\u20137. https:\/\/doi.org\/10.1097\/TP.0000000000002098.","journal-title":"Transplantation"},{"issue":"4","key":"527_CR85","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/hep.20400","volume":"40","author":"F Hong","year":"2004","unstructured":"Hong F, Radaeva S, Pan HN, Tian Z, Veech R, Gao B. Interleukin 6 alleviates hepatic steatosis and ischemia\/reperfusion injury in mice with fatty liver disease. Hepatology. 2004;40(4):933\u201341. https:\/\/doi.org\/10.1002\/hep.20400.","journal-title":"Hepatology"},{"issue":"6","key":"527_CR86","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jhep.2019.07.019","volume":"71","author":"Q Guo","year":"2019","unstructured":"Guo Q, Furuta K, Lucien F, Gutierrez Sanchez LH, Hirsova P, Krishnan A, et al. Integrin beta(1)-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH. J Hepatol. 2019;71(6):1193\u2013205. https:\/\/doi.org\/10.1016\/j.jhep.2019.07.019.","journal-title":"J Hepatol"},{"issue":"8","key":"527_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100524","volume":"4","author":"SJ Wallace","year":"2022","unstructured":"Wallace SJ, Tacke F, Schwabe RF, Henderson NC. Understanding the cellular interactome of non-alcoholic fatty liver disease. JHEP Rep. 2022;4(8):100524. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100524.","journal-title":"JHEP Rep"},{"issue":"4","key":"527_CR88","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/HEP.0000000000001018","volume":"81","author":"U Ojha","year":"2025","unstructured":"Ojha U, Kim S, Rhee CY, You J, Choi YH, Yoon SH, et al. Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to prevent liver fibrosis. Hepatology. 2025;81(4):1228\u201343. https:\/\/doi.org\/10.1097\/HEP.0000000000001018.","journal-title":"Hepatology"},{"issue":"3","key":"527_CR89","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/a-2128-5907","volume":"43","author":"SA Cooper","year":"2023","unstructured":"Cooper SA, Kostallari E, Shah VH. Angiocrine signaling in sinusoidal health and disease. Semin Liver Dis. 2023;43(3):245\u201357. https:\/\/doi.org\/10.1055\/a-2128-5907.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"527_CR90","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.taap.2011.12.013","volume":"259","author":"T Minamino","year":"2012","unstructured":"Minamino T, Ito Y, Ohkubo H, Hosono K, Suzuki T, Sato T, et al. Thromboxane A(2) receptor signaling promotes liver tissue repair after toxic injury through the enhancement of macrophage recruitment. Toxicol Appl Pharmacol. 2012;259(1):104\u201314. https:\/\/doi.org\/10.1016\/j.taap.2011.12.013.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"8","key":"527_CR91","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00210-020-01848-8","volume":"393","author":"YS Mohamed","year":"2020","unstructured":"Mohamed YS, Abdelsalam RM, Attia AS, Abdel-Aziz MT, El-Tanbouly DM. Regulation of liver regeneration by prostaglandin E(2) and thromboxane A(2) following partial hepatectomy in rats. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(8):1437\u201346. https:\/\/doi.org\/10.1007\/s00210-020-01848-8.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"8","key":"527_CR92","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/10937404.2023.2261848","volume":"26","author":"R Allison","year":"2023","unstructured":"Allison R, Guraka A, Shawa IT, Tripathi G, Moritz W, Kermanizadeh A. Drug induced liver injury - a 2023 update. J Toxicol Environ Health B Crit Rev. 2023;26(8):442\u201367. https:\/\/doi.org\/10.1080\/10937404.2023.2261848.","journal-title":"J Toxicol Environ Health B Crit Rev"},{"issue":"3","key":"527_CR93","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/hep.32689","volume":"77","author":"RJ Fontana","year":"2023","unstructured":"Fontana RJ, Liou I, Reuben A, Suzuki A, Fiel MI, Lee W, et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2023;77(3):1036\u201365. https:\/\/doi.org\/10.1002\/hep.32689.","journal-title":"Hepatology"},{"key":"527_CR94","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.redox.2018.04.019","volume":"17","author":"M Yan","year":"2018","unstructured":"Yan M, Huo Y, Yin S, Hu H. Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions. Redox Biol. 2018;17:274\u201383. https:\/\/doi.org\/10.1016\/j.redox.2018.04.019.","journal-title":"Redox Biol"},{"issue":"1","key":"527_CR95","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/20014091111677","volume":"31","author":"JG Bessems","year":"2001","unstructured":"Bessems JG, Vermeulen NP. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol. 2001;31(1):55\u2013138. https:\/\/doi.org\/10.1080\/20014091111677.","journal-title":"Crit Rev Toxicol"},{"issue":"5","key":"527_CR96","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/15353702221147563","volume":"248","author":"G Luo","year":"2023","unstructured":"Luo G, Huang L, Zhang Z. The molecular mechanisms of acetaminophen-induced hepatotoxicity and its potential therapeutic targets. Exp Biol Med (Maywood). 2023;248(5):412\u201324. https:\/\/doi.org\/10.1177\/15353702221147563.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"527_CR97","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1055\/s-2007-991515","volume":"27","author":"LD DeLeve","year":"2007","unstructured":"DeLeve LD. Hepatic microvasculature in liver injury. Semin Liver Dis. 2007;27(4):390\u2013400. https:\/\/doi.org\/10.1055\/s-2007-991515.","journal-title":"Semin Liver Dis"},{"issue":"3","key":"527_CR98","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00204-015-1456-2","volume":"89","author":"ES Bjornsson","year":"2015","unstructured":"Bjornsson ES. Drug-induced liver injury: an overview over the most critical compounds. Arch Toxicol. 2015;89(3):327\u201334. https:\/\/doi.org\/10.1007\/s00204-015-1456-2.","journal-title":"Arch Toxicol"},{"issue":"1","key":"527_CR99","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00204-019-02582-8","volume":"94","author":"S Hessel-Pras","year":"2020","unstructured":"Hessel-Pras S, Braeuning A, Guenther G, Adawy A, Enge AM, Ebmeyer J, et al. The pyrrolizidine alkaloid senecionine induces CYP-dependent destruction of sinusoidal endothelial cells and cholestasis in mice. Arch Toxicol. 2020;94(1):219\u201329. https:\/\/doi.org\/10.1007\/s00204-019-02582-8.","journal-title":"Arch Toxicol"},{"issue":"9","key":"527_CR100","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/jcp.55.9.676","volume":"55","author":"M Zuckerman","year":"2002","unstructured":"Zuckerman M, Steenkamp V, Stewart MJ. Hepatic veno-occlusive disease as a result of a traditional remedy: confirmation of toxic pyrrolizidine alkaloids as the cause, using an in vitro technique. J Clin Pathol. 2002;55(9):676\u20139. https:\/\/doi.org\/10.1136\/jcp.55.9.676.","journal-title":"J Clin Pathol"},{"issue":"3","key":"527_CR101","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/hep.510280324","volume":"28","author":"JA Lawson","year":"1998","unstructured":"Lawson JA, Fisher MA, Simmons CA, Farhood A, Jaeschke H. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury. Hepatology. 1998;28(3):761\u20137. https:\/\/doi.org\/10.1002\/hep.510280324.","journal-title":"Hepatology"},{"issue":"5 Pt 1","key":"527_CR102","doi-asserted-by":"publisher","first-page":"G1195","DOI":"10.1152\/ajpgi.1997.272.5.G1195","volume":"272","author":"JG Chosay","year":"1997","unstructured":"Chosay JG, Essani NA, Dunn CJ, Jaeschke H. Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am J Physiol. 1997;272(5 Pt 1):G1195\u2013200. https:\/\/doi.org\/10.1152\/ajpgi.1997.272.5.G1195.","journal-title":"Am J Physiol"},{"issue":"4","key":"527_CR103","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3350\/cmh.2024.0315","volume":"30","author":"M Yan","year":"2024","unstructured":"Yan M, Man S, Ma L, Guo L, Huang L, Gao W. Immunological mechanisms in steatotic liver diseases: an overview and clinical perspectives. Clin Mol Hepatol. 2024;30(4):620\u201348. https:\/\/doi.org\/10.3350\/cmh.2024.0315.","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"527_CR104","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003.","journal-title":"J Hepatol"},{"issue":"4","key":"527_CR105","doi-asserted-by":"publisher","first-page":"100316","DOI":"10.1016\/j.jhepr.2021.100316","volume":"3","author":"Y Iwakiri","year":"2021","unstructured":"Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy. JHEP Rep. 2021;3(4):100316. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100316.","journal-title":"JHEP Rep"},{"issue":"12","key":"527_CR106","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.7150\/thno.83714","volume":"13","author":"JH Hwang","year":"2023","unstructured":"Hwang JH, Heo W, Park JI, Kim KM, Oh HT, Yoo GD, et al. Endothelial TAZ inhibits capillarization of liver sinusoidal endothelium and damage-induced liver fibrosis via nitric oxide production. Theranostics. 2023;13(12):4182\u201396. https:\/\/doi.org\/10.7150\/thno.83714.","journal-title":"Theranostics"},{"issue":"4","key":"527_CR107","doi-asserted-by":"publisher","first-page":"e70063","DOI":"10.1111\/liv.70063","volume":"45","author":"J Wang","year":"2025","unstructured":"Wang J, Guo Y, Hu J, Peng J. STING activation in various cell types in metabolic dysfunction-associated steatotic liver disease. Liver Int. 2025;45(4):e70063. https:\/\/doi.org\/10.1111\/liv.70063.","journal-title":"Liver Int"},{"issue":"3","key":"527_CR108","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/CIRCRESAHA.120.318003","volume":"128","author":"NA Abumrad","year":"2021","unstructured":"Abumrad NA, Cabodevilla AG, Samovski D, Pietka T, Basu D, Goldberg IJ. Endothelial cell receptors in tissue lipid uptake and metabolism. Circ Res. 2021;128(3):433\u201350. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.318003.","journal-title":"Circ Res"},{"issue":"3","key":"527_CR109","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cmet.2020.01.013","volume":"31","author":"J Simon","year":"2020","unstructured":"Simon J, Nunez-Garcia M, Fernandez-Tussy P, Barbier-Torres L, Fernandez-Ramos D, Gomez-Santos B, et al. Targeting hepatic glutaminase 1 ameliorates non-alcoholic steatohepatitis by restoring very-low-density lipoprotein triglyceride assembly. Cell Metab. 2020;31(3):605-622.e10. https:\/\/doi.org\/10.1016\/j.cmet.2020.01.013.","journal-title":"Cell Metab"},{"key":"527_CR110","doi-asserted-by":"publisher","first-page":"114763","DOI":"10.1016\/j.ecoenv.2023.114763","volume":"255","author":"M Guo","year":"2023","unstructured":"Guo M, Li M, Chen L, Wang H, Wang J, Niu P, et al. Glutaminase 1 isoform up-regulation associated with lipid metabolism disorder induced by methyl tertiary-butyl ether in male rats. Ecotoxicol Environ Saf. 2023;255:114763. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.114763.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"12","key":"527_CR111","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1038\/s41588-025-02407-8","volume":"57","author":"Z Li","year":"2025","unstructured":"Li Z, Luo G, Gan C, Zhang H, Li L, Zhang X, et al. Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease. Nat Genet. 2025;57(12):3112\u201325. https:\/\/doi.org\/10.1038\/s41588-025-02407-8.","journal-title":"Nat Genet"},{"issue":"6","key":"527_CR112","doi-asserted-by":"publisher","first-page":"101366","DOI":"10.1016\/j.jhepr.2025.101366","volume":"7","author":"PE Rautou","year":"2025","unstructured":"Rautou PE, Chotkoe S, Biquard L, Wettstein G, van der Graaff D, Liu Y, et al. Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment. JHEP Rep. 2025;7(6):101366. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101366.","journal-title":"JHEP Rep"},{"issue":"10","key":"527_CR113","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2468-1253(23)00206-6","volume":"8","author":"M Israelsen","year":"2023","unstructured":"Israelsen M, Torp N, Johansen S, Thiele M, Krag A. MetALD: new opportunities to understand the role of alcohol in steatotic liver disease. Lancet Gastroenterol Hepatol. 2023;8(10):866\u20138. https:\/\/doi.org\/10.1016\/S2468-1253(23)00206-6.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"527_CR114","doi-asserted-by":"publisher","first-page":"606","DOI":"10.7150\/ijbs.90781","volume":"20","author":"E Jung","year":"2024","unstructured":"Jung E, Baek EB, Hong EJ, Kang JH, Park S, Park S, et al. TXNIP in liver sinusoidal endothelial cells ameliorates alcohol-associated liver disease via nitric oxide production. Int J Biol Sci. 2024;20(2):606\u201320. https:\/\/doi.org\/10.7150\/ijbs.90781.","journal-title":"Int J Biol Sci"},{"key":"527_CR115","doi-asserted-by":"publisher","first-page":"139239","DOI":"10.1155\/2013\/139239","volume":"2013","author":"K Makki","year":"2013","unstructured":"Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2013;2013:139239. https:\/\/doi.org\/10.1155\/2013\/139239.","journal-title":"ISRN Inflamm"},{"issue":"7","key":"527_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9070762","volume":"9","author":"C Jimenez-Cortegana","year":"2021","unstructured":"Jimenez-Cortegana C, Garcia-Galey A, Tami M, Del Pino P, Carmona I, Lopez S, et al. Role of leptin in non-alcoholic fatty liver disease. Biomedicines. 2021;9(7):762. https:\/\/doi.org\/10.3390\/biomedicines9070762.","journal-title":"Biomedicines"},{"issue":"11","key":"527_CR117","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00109-016-1446-8","volume":"94","author":"A Eguchi","year":"2016","unstructured":"Eguchi A, Lazic M, Armando AM, Phillips SA, Katebian R, Maraka S, et al. Circulating adipocyte-derived extracellular vesicles are novel markers of metabolic stress. J Mol Med (Berl). 2016;94(11):1241\u201353. https:\/\/doi.org\/10.1007\/s00109-016-1446-8.","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"527_CR118","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/JLB.3MIR0321-156R","volume":"111","author":"M Babuta","year":"2022","unstructured":"Babuta M, Szabo G. Extracellular vesicles in inflammation: focus on the microRNA cargo of EVs in modulation of liver diseases. J Leukoc Biol. 2022;111(1):75\u201392. https:\/\/doi.org\/10.1002\/JLB.3MIR0321-156R.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"527_CR119","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1172\/JCI90086","volume":"127","author":"C Geraud","year":"2017","unstructured":"Geraud C, Koch PS, Zierow J, Klapproth K, Busch K, Olsavszky V, et al. GATA4-dependent organ-specific endothelial differentiation controls liver development and embryonic hematopoiesis. J Clin Invest. 2017;127(3):1099\u2013114. https:\/\/doi.org\/10.1172\/JCI90086.","journal-title":"J Clin Invest"},{"issue":"11","key":"527_CR120","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1161\/ATVBAHA.109.193540","volume":"29","author":"A Young","year":"2009","unstructured":"Young A, Wu W, Sun W, Benjamin Larman H, Wang N, Li YS, et al. Flow activation of AMP-activated protein kinase in vascular endothelium leads to Kruppel-like factor 2 expression. Arterioscler Thromb Vasc Biol. 2009;29(11):1902\u20138. https:\/\/doi.org\/10.1161\/ATVBAHA.109.193540.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"527_CR121","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/hep.27376","volume":"61","author":"LD DeLeve","year":"2015","unstructured":"DeLeve LD. Liver sinusoidal endothelial cells in hepatic fibrosis. Hepatology. 2015;61(5):1740\u20136. https:\/\/doi.org\/10.1002\/hep.27376.","journal-title":"Hepatology"},{"issue":"8622","key":"527_CR122","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/s0140-6736(88)90813-6","volume":"2","author":"SA Clark","year":"1988","unstructured":"Clark SA, Angus HB, Cook HB, George PM, Oxner RB, Fraser R. Defenestration of hepatic sinusoids as a cause of hyperlipoproteinaemia in alcoholics. Lancet. 1988;2(8622):1225\u20137. https:\/\/doi.org\/10.1016\/s0140-6736(88)90813-6.","journal-title":"Lancet"},{"issue":"1","key":"527_CR123","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jhep.2024.02.032","volume":"81","author":"S He","year":"2024","unstructured":"He S, Luo Y, Ma W, Wang X, Yan C, Hao W, et al. Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis. J Hepatol. 2024;81(1):135\u201348. https:\/\/doi.org\/10.1016\/j.jhep.2024.02.032.","journal-title":"J Hepatol"},{"issue":"5","key":"527_CR124","doi-asserted-by":"publisher","first-page":"100145","DOI":"10.1016\/j.jhepr.2020.100145","volume":"2","author":"S Guixe-Muntet","year":"2020","unstructured":"Guixe-Muntet S, Ortega-Ribera M, Wang C, Selicean S, Andreu I, Kechagia JZ, et al. Nuclear deformation mediates liver cell mechanosensing in cirrhosis. JHEP Rep. 2020;2(5):100145. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100145.","journal-title":"JHEP Rep"},{"issue":"6","key":"527_CR125","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/cells13060538","volume":"13","author":"S Asada","year":"2024","unstructured":"Asada S, Kaji K, Nishimura N, Koizumi A, Matsuda T, Tanaka M, et al. Tofogliflozin delays portal hypertension and hepatic fibrosis by inhibiting sinusoidal capillarization in cirrhotic rats. Cells. 2024;13(6):538. https:\/\/doi.org\/10.3390\/cells13060538.","journal-title":"Cells"},{"issue":"6","key":"527_CR126","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1053\/jhep.2002.36934","volume":"36","author":"H Rensing","year":"2002","unstructured":"Rensing H, Bauer I, Zhang JX, Paxian M, Pannen B, Yokoyama Y, et al. Endothelin-1 and heme oxygenase-1 as modulators of sinusoidal tone in the stress-exposed rat liver. Hepatology. 2002;36(6):1453\u201365. https:\/\/doi.org\/10.1053\/jhep.2002.36934.","journal-title":"Hepatology"},{"issue":"4","key":"527_CR127","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/s0168-8278(03)00347-7","volume":"39","author":"M Graupera","year":"2003","unstructured":"Graupera M, Garcia-Pagan JC, Pares M, Abraldes JG, Rosello J, Bosch J, et al. Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers. J Hepatol. 2003;39(4):515\u201321. https:\/\/doi.org\/10.1016\/s0168-8278(03)00347-7.","journal-title":"J Hepatol"},{"issue":"6","key":"527_CR128","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1002\/hep.23596","volume":"51","author":"CJ Steib","year":"2010","unstructured":"Steib CJ, Bilzer M, op den Winkel M, Pfeiler S, Hartmann AC, Hennenberg M, et al. Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis. Hepatology. 2010;51(6):2086\u201396. https:\/\/doi.org\/10.1002\/hep.23596.","journal-title":"Hepatology"},{"issue":"10","key":"527_CR129","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/j.1582-4934.2012.01563.x","volume":"16","author":"E Rosado","year":"2012","unstructured":"Rosado E, Rodriguez-Vilarrupla A, Gracia-Sancho J, Monclus M, Bosch J, Garcia-Pagan JC. Interaction between NO and COX pathways modulating hepatic endothelial cells from control and cirrhotic rats. J Cell Mol Med. 2012;16(10):2461\u201370. https:\/\/doi.org\/10.1111\/j.1582-4934.2012.01563.x.","journal-title":"J Cell Mol Med"},{"issue":"21","key":"527_CR130","doi-asserted-by":"publisher","first-page":"11483","DOI":"10.1073\/pnas.1922608117","volume":"117","author":"S Liu","year":"2020","unstructured":"Liu S, Luttrell LM, Premont RT, Rockey DC. beta-Arrestin2 is a critical component of the GPCR-eNOS signalosome. Proc Natl Acad Sci U S A. 2020;117(21):11483\u201392. https:\/\/doi.org\/10.1073\/pnas.1922608117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8022","key":"527_CR131","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41586-024-07630-7","volume":"631","author":"M Bosch","year":"2024","unstructured":"Bosch M, Kallin N, Donakonda S, Zhang JD, Wintersteller H, Hegenbarth S, et al. A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection. Nature. 2024;631(8022):867\u201375. https:\/\/doi.org\/10.1038\/s41586-024-07630-7.","journal-title":"Nature"},{"issue":"10381","key":"527_CR132","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","volume":"401","author":"WJ Jeng","year":"2023","unstructured":"Jeng WJ, Papatheodoridis GV, Lok ASF. Hepatitis B. Lancet. 2023;401(10381):1039\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(22)01468-4.","journal-title":"Lancet"},{"issue":"1","key":"527_CR133","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2017.08.034","volume":"68","author":"SM Lemon","year":"2018","unstructured":"Lemon SM, Ott JJ, Van Damme P, Shouval D. Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J Hepatol. 2018;68(1):167\u201384. https:\/\/doi.org\/10.1016\/j.jhep.2017.08.034.","journal-title":"J Hepatol"},{"key":"527_CR134","doi-asserted-by":"publisher","first-page":"17086","DOI":"10.1038\/nrdp.2017.86","volume":"3","author":"N Kamar","year":"2017","unstructured":"Kamar N, Izopet J, Pavio N, Aggarwal R, Labrique A, Wedemeyer H, et al. Hepatitis E virus infection. Nat Rev Dis Primers. 2017;3:17086. https:\/\/doi.org\/10.1038\/nrdp.2017.86.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"527_CR135","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/hep4.1480","volume":"4","author":"A Do","year":"2020","unstructured":"Do A, Reau NS. Chronic viral hepatitis: Current management and future directions. Hepatol Commun. 2020;4(3):329\u201341. https:\/\/doi.org\/10.1002\/hep4.1480.","journal-title":"Hepatol Commun"},{"issue":"10","key":"527_CR136","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","volume":"8","author":"Polaris Observatory Collaborators","year":"2023","unstructured":"Polaris Observatory Collaborators. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: A modelling study. Lancet Gastroenterol Hepatol. 2023;8(10):879\u2013907. https:\/\/doi.org\/10.1016\/S2468-1253(23)00197-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"527_CR137","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C de Martel","year":"2020","unstructured":"de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: A worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180\u201390. https:\/\/doi.org\/10.1016\/S2214-109X(19)30488-7.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"527_CR138","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/hep.22751","volume":"49","author":"J Wu","year":"2009","unstructured":"Wu J, Meng Z, Jiang M, Pei R, Trippler M, Broering R, et al. Hepatitis B virus suppresses Toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology. 2009;49(4):1132\u201340. https:\/\/doi.org\/10.1002\/hep.22751.","journal-title":"Hepatology"},{"issue":"1","key":"527_CR139","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00430-014-0370-1","volume":"204","author":"E Zhang","year":"2015","unstructured":"Zhang E, Lu M. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection. Med Microbiol Immunol. 2015;204(1):11\u201320. https:\/\/doi.org\/10.1007\/s00430-014-0370-1.","journal-title":"Med Microbiol Immunol"},{"key":"527_CR140","doi-asserted-by":"publisher","first-page":"965018","DOI":"10.3389\/fimmu.2022.965018","volume":"13","author":"Y Du","year":"2022","unstructured":"Du Y, Wu J, Liu J, Zheng X, Yang D, Lu M. Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection. Front Immunol. 2022;13:965018. https:\/\/doi.org\/10.3389\/fimmu.2022.965018.","journal-title":"Front Immunol"},{"issue":"4","key":"527_CR141","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jhep.2019.05.013","volume":"71","author":"S Yang","year":"2019","unstructured":"Yang S, Wang L, Pan W, Bayer W, Thoens C, Heim K, et al. MMP2\/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance. J Hepatol. 2019;71(4):685\u201398. https:\/\/doi.org\/10.1016\/j.jhep.2019.05.013.","journal-title":"J Hepatol"},{"issue":"2","key":"527_CR142","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.gastro.2014.10.040","volume":"148","author":"S Giugliano","year":"2015","unstructured":"Giugliano S, Kriss M, Golden-Mason L, Dobrinskikh E, Stone AE, Soto-Gutierrez A, et al. Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication. Gastroenterology. 2015;148(2):392-402.e13. https:\/\/doi.org\/10.1053\/j.gastro.2014.10.040.","journal-title":"Gastroenterology"},{"issue":"2","key":"527_CR143","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/hep.26571","volume":"59","author":"IA Rowe","year":"2014","unstructured":"Rowe IA, Galsinh SK, Wilson GK, Parker R, Durant S, Lazar C, et al. Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication. Hepatology. 2014;59(2):375\u201384. https:\/\/doi.org\/10.1002\/hep.26571.","journal-title":"Hepatology"},{"issue":"6","key":"527_CR144","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.jhep.2008.01.028","volume":"48","author":"R Broering","year":"2008","unstructured":"Broering R, Wu J, Meng Z, Hilgard P, Lu M, Trippler M, et al. Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. J Hepatol. 2008;48(6):914\u201322. https:\/\/doi.org\/10.1016\/j.jhep.2008.01.028.","journal-title":"J Hepatol"},{"key":"527_CR145","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ijcard.2018.04.058","volume":"271","author":"FP Schmidt","year":"2018","unstructured":"Schmidt FP, Zimmermann T, Wenz T, Schnorbus B, Ostad MA, Feist C, et al. Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial function. Int J Cardiol. 2018;271:296\u2013300. https:\/\/doi.org\/10.1016\/j.ijcard.2018.04.058.","journal-title":"Int J Cardiol"},{"issue":"11","key":"527_CR146","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1111\/tri.14000","volume":"34","author":"A Caballero-Marcos","year":"2021","unstructured":"Caballero-Marcos A, Romero-Cristobal M, Puerto M, Fernandez-Yunquera A, Dieguez L, Navarrete C, et al. HCV eradication in recurrent hepatitis C after liver transplantation normalizes enhanced endothelial activation. Transpl Int. 2021;34(11):2214\u201325. https:\/\/doi.org\/10.1111\/tri.14000.","journal-title":"Transpl Int"},{"issue":"4","key":"527_CR147","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jhep.2024.09.044","volume":"82","author":"Y Lu","year":"2025","unstructured":"Lu Y, Liu Y, Zuo X, Li G, Wang J, Liu J, et al. CXCL12+ tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma. J Hepatol. 2025;82(4):634\u201348. https:\/\/doi.org\/10.1016\/j.jhep.2024.09.044.","journal-title":"J Hepatol"},{"issue":"1","key":"527_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2023.0125","volume":"30","author":"K Sankar","year":"2024","unstructured":"Sankar K, Gong J, Osipov A, Miles SA, Kosari K, Nissen NN, et al. Recent advances in the management of hepatocellular carcinoma. Clin Mol Hepatol. 2024;30(1):1\u201315. https:\/\/doi.org\/10.3350\/cmh.2023.0125.","journal-title":"Clin Mol Hepatol"},{"issue":"11","key":"527_CR149","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1111\/cas.70179","volume":"116","author":"D Matoba","year":"2025","unstructured":"Matoba D, Noda T, Kobayashi S, Sakano Y, Matsumoto K, Yamanaka C, et al. Tumor endothelial cells induce M2 macrophage polarization via IL-4, enhancing tumor growth in hepatocellular carcinoma. Cancer Sci. 2025;116(11):2972\u201385. https:\/\/doi.org\/10.1111\/cas.70179.","journal-title":"Cancer Sci"},{"issue":"1","key":"527_CR150","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13046-018-0777-4","volume":"37","author":"F Xu","year":"2018","unstructured":"Xu F, Jin T, Zhu Y, Dai C. Immune checkpoint therapy in liver cancer. J Exp Clin Cancer Res. 2018;37(1):110. https:\/\/doi.org\/10.1186\/s13046-018-0777-4.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"527_CR151","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s00262-019-02427-4","volume":"68","author":"B Langhans","year":"2019","unstructured":"Langhans B, Nischalke HD, Kramer B, Dold L, Lutz P, Mohr R, et al. Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma. Cancer Immunol Immunother. 2019;68(12):2055\u201366. https:\/\/doi.org\/10.1007\/s00262-019-02427-4.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"527_CR152","doi-asserted-by":"publisher","first-page":"G138","DOI":"10.1152\/ajpgi.00411.2016","volume":"313","author":"JCR Wadkin","year":"2017","unstructured":"Wadkin JCR, Patten DA, Kamarajah SK, Shepherd EL, Novitskaya V, Berditchevski F, et al. CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinoma. Am J Physiol Gastrointest Liver Physiol. 2017;313(2):G138\u201349. https:\/\/doi.org\/10.1152\/ajpgi.00411.2016.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"527_CR153","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13046-024-03082-z","volume":"43","author":"K Zhang","year":"2024","unstructured":"Zhang K, Zhu Z, Jia R, Wang NA, Shi M, Wang Y, et al. CD151-enriched migrasomes mediate hepatocellular carcinoma invasion by conditioning cancer cells and promoting angiogenesis. J Exp Clin Cancer Res. 2024;43(1):160. https:\/\/doi.org\/10.1186\/s13046-024-03082-z.","journal-title":"J Exp Clin Cancer Res"},{"issue":"24","key":"527_CR154","doi-asserted-by":"publisher","first-page":"13590","DOI":"10.3390\/ijms252413590","volume":"25","author":"K Oura","year":"2024","unstructured":"Oura K, Morishita A, Tadokoro T, Fujita K, Tani J, Kobara H. Immune microenvironment and the effect of vascular endothelial growth factor inhibition in hepatocellular carcinoma. Int J Mol Sci. 2024;25(24):13590. https:\/\/doi.org\/10.3390\/ijms252413590.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"527_CR155","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3390\/cancers17111860","volume":"17","author":"S Wu","year":"2025","unstructured":"Wu S, Anand N, Guo Z, Li M, Santiago Figueroa M, Jung L, et al. Bridging immune evasion and vascular dynamics for novel therapeutic frontiers in hepatocellular carcinoma. Cancers (Basel). 2025;17(11):1860. https:\/\/doi.org\/10.3390\/cancers17111860.","journal-title":"Cancers (Basel)"},{"key":"527_CR156","doi-asserted-by":"publisher","first-page":"218335","DOI":"10.1016\/j.canlet.2026.218335","volume":"645","author":"XX Wang","year":"2026","unstructured":"Wang XX, Jin S, Chao X, Liu Y, Cheng YH, Ji H, et al. Integrative single-cell and spatial transcriptomic reveals S100A16(+) tumor endothelial cells drive angiogenesis and immunosuppression in hepatocellular carcinoma. Cancer Lett. 2026;645:218335. https:\/\/doi.org\/10.1016\/j.canlet.2026.218335.","journal-title":"Cancer Lett"},{"issue":"1","key":"527_CR157","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1186\/s12885-017-3823-2","volume":"17","author":"A Benedicto","year":"2017","unstructured":"Benedicto A, Marquez J, Herrero A, Olaso E, Kolaczkowska E, Arteta B. Decreased expression of the beta(2) integrin on tumor cells is associated with a reduction in liver metastasis of colorectal cancer in mice. BMC Cancer. 2017;17(1):827. https:\/\/doi.org\/10.1186\/s12885-017-3823-2.","journal-title":"BMC Cancer"},{"issue":"1","key":"527_CR158","doi-asserted-by":"publisher","first-page":"13111","DOI":"10.1038\/s41598-019-49473-7","volume":"9","author":"A Benedicto","year":"2019","unstructured":"Benedicto A, Herrero A, Romayor I, Marquez J, Smedsrod B, Olaso E, et al. Liver sinusoidal endothelial cell ICAM-1 mediated tumor\/endothelial crosstalk drives the development of liver metastasis by initiating inflammatory and angiogenic responses. Sci Rep. 2019;9(1):13111. https:\/\/doi.org\/10.1038\/s41598-019-49473-7.","journal-title":"Sci Rep"},{"issue":"1","key":"527_CR159","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41467-019-08538-x","volume":"10","author":"X Yu","year":"2019","unstructured":"Yu X, Chen L, Liu J, Dai B, Xu G, Shen G, et al. Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis. Nat Commun. 2019;10(1):574. https:\/\/doi.org\/10.1038\/s41467-019-08538-x.","journal-title":"Nat Commun"},{"issue":"4","key":"527_CR160","doi-asserted-by":"publisher","first-page":"e0669","DOI":"10.1097\/HC9.0000000000000669","volume":"9","author":"A Benedicto","year":"2025","unstructured":"Benedicto A, Herrero A, Lopategi A, Friedman SL, Boyano MD, Arteta B. Depletion of tumor-reactive HSCs reveals their significance during different stages of liver metastasis. Hepatol Commun. 2025;9(4):e0669. https:\/\/doi.org\/10.1097\/HC9.0000000000000669.","journal-title":"Hepatol Commun"},{"key":"527_CR161","doi-asserted-by":"publisher","first-page":"e18362","DOI":"10.7717\/peerj.18362","volume":"12","author":"J Sun","year":"2024","unstructured":"Sun J, Zhang S, Liu Y, Liu K, Gu X. Exploring tumor endothelial cells heterogeneity in hepatocellular carcinoma: Insights from single-cell sequencing and pseudotime analysis. PeerJ. 2024;12:e18362. https:\/\/doi.org\/10.7717\/peerj.18362.","journal-title":"PeerJ"},{"issue":"5","key":"527_CR162","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.jhep.2016.05.017","volume":"65","author":"J Shen","year":"2016","unstructured":"Shen J, Jiang F, Yang Y, Huang G, Pu F, Liu Q, et al. 14\u20133-3eta is a novel growth-promoting and angiogenic factor in hepatocellular carcinoma. J Hepatol. 2016;65(5):953\u201362. https:\/\/doi.org\/10.1016\/j.jhep.2016.05.017.","journal-title":"J Hepatol"},{"issue":"1","key":"527_CR163","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13046-018-1005-y","volume":"37","author":"Y Qiu","year":"2018","unstructured":"Qiu Y, Dai Y, Zhang C, Yang Y, Jin M, Shan W, et al. Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14\u20133-3eta\/NF-kappaB feedback loop. J Exp Clin Cancer Res. 2018;37(1):321. https:\/\/doi.org\/10.1186\/s13046-018-1005-y.","journal-title":"J Exp Clin Cancer Res"},{"key":"527_CR164","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003851","author":"M Jin","year":"2025","unstructured":"Jin M, Du X, Dong N, Feng Z, Sun Y, Song S, et al. A cigarette compound-induced tumor microenvironment promotes sorafenib resistance in hepatocellular carcinoma via the 14\u20133-3eta-modified tumor-associated proteome. Chin Med J (Engl). 2025. https:\/\/doi.org\/10.1097\/CM9.0000000000003851.","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"527_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189310","volume":"1880","author":"W Zhang","year":"2025","unstructured":"Zhang W, Hong X, Xiao Y, Wang H, Zeng X. Sorafenib resistance and therapeutic strategies in hepatocellular carcinoma. Biochim Biophys Acta Rev Cancer. 2025;1880(3):189310. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189310.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"8","key":"527_CR166","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/liv.15953","volume":"44","author":"Y Qin","year":"2024","unstructured":"Qin Y, Han S, Yu Y, Qi D, Ran M, Yang M, et al. Lenvatinib in hepatocellular carcinoma: resistance mechanisms and strategies for improved efficacy. Liver Int. 2024;44(8):1808\u201331. https:\/\/doi.org\/10.1111\/liv.15953.","journal-title":"Liver Int"},{"issue":"4","key":"527_CR167","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","volume":"79","author":"AD Ladd","year":"2024","unstructured":"Ladd AD, Duarte S, Sahin I, Zarrinpar A. Mechanisms of drug resistance in HCC. Hepatology. 2024;79(4):926\u201340. https:\/\/doi.org\/10.1097\/HEP.0000000000000237.","journal-title":"Hepatology"},{"issue":"6","key":"527_CR168","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.jhep.2015.01.006","volume":"62","author":"A Carambia","year":"2015","unstructured":"Carambia A, Freund B, Schwinge D, Bruns OT, Salmen SC, Ittrich H, et al. Nanoparticle-based autoantigen delivery to treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice. J Hepatol. 2015;62(6):1349\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2015.01.006.","journal-title":"J Hepatol"},{"issue":"8","key":"527_CR169","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1042\/CS20140125","volume":"127","author":"D Hide","year":"2014","unstructured":"Hide D, Ortega-Ribera M, Fernandez-Iglesias A, Fondevila C, Salvado MJ, Arola L, et al. A novel form of the human manganese superoxide dismutase protects rat and human livers undergoing ischaemia and reperfusion injury. Clin Sci (Lond). 2014;127(8):527\u201337. https:\/\/doi.org\/10.1042\/CS20140125.","journal-title":"Clin Sci (Lond)"},{"key":"527_CR170","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jss.2017.09.048","volume":"222","author":"T Ito","year":"2018","unstructured":"Ito T, Kuriyama N, Kato H, Matsuda A, Mizuno S, Usui M, et al. Sinusoidal protection by sphingosine-1-phosphate receptor 1 agonist in liver ischemia-reperfusion injury. J Surg Res. 2018;222:139\u201352. https:\/\/doi.org\/10.1016\/j.jss.2017.09.048.","journal-title":"J Surg Res"},{"issue":"3","key":"527_CR171","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/hum.2018.166","volume":"30","author":"N Yadav","year":"2019","unstructured":"Yadav N, Jaber FL, Sharma Y, Gupta P, Viswanathan P, Gupta S. Efficient reconstitution of hepatic microvasculature by endothelin receptor antagonism in liver sinusoidal endothelial cells. Hum Gene Ther. 2019;30(3):365\u201377. https:\/\/doi.org\/10.1089\/hum.2018.166.","journal-title":"Hum Gene Ther"},{"issue":"2","key":"527_CR172","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.clinre.2018.08.014","volume":"43","author":"Z Liu","year":"2019","unstructured":"Liu Z, Lai CH, Zhang X, Luo J, Huang X, Qi X, et al. Simvastatin ameliorates total liver ischemia\/reperfusion injury via KLF2-mediated mechanism in rats. Clin Res Hepatol Gastroenterol. 2019;43(2):171\u20138. https:\/\/doi.org\/10.1016\/j.clinre.2018.08.014.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"4","key":"527_CR173","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1053\/jhep.2001.23073","volume":"33","author":"W Zhou","year":"2001","unstructured":"Zhou W, Zhang Y, Hosch MS, Lang A, Zwacka RM, Engelhardt JF. Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia\/reperfusion. Hepatology. 2001;33(4):902\u201314. https:\/\/doi.org\/10.1053\/jhep.2001.23073.","journal-title":"Hepatology"},{"issue":"3","key":"527_CR174","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jhep.2014.10.007","volume":"62","author":"G Mandili","year":"2015","unstructured":"Mandili G, Alchera E, Merlin S, Imarisio C, Chandrashekar BR, Riganti C, et al. Mouse hepatocytes and LSEC proteome reveal novel mechanisms of ischemia\/reperfusion damage and protection by A2aR stimulation. J Hepatol. 2015;62(3):573\u201380. https:\/\/doi.org\/10.1016\/j.jhep.2014.10.007.","journal-title":"J Hepatol"},{"issue":"9","key":"527_CR175","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1111\/liv.12827","volume":"35","author":"H Ajamieh","year":"2015","unstructured":"Ajamieh H, Farrell GC, McCuskey RS, Yu J, Chu E, Wong HJ, et al. Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation. Liver Int. 2015;35(9):2174\u201386. https:\/\/doi.org\/10.1111\/liv.12827.","journal-title":"Liver Int"},{"issue":"3","key":"527_CR176","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/s1091-255x(01)80055-x","volume":"5","author":"R Ricciardi","year":"2001","unstructured":"Ricciardi R, Schaffer BK, Shah SA, Quarfordt SH, Banner BF, Wheeler SM, et al. Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia\/reperfusion injury. J Gastrointest Surg. 2001;5(3):322\u20139. https:\/\/doi.org\/10.1016\/s1091-255x(01)80055-x.","journal-title":"J Gastrointest Surg"},{"issue":"2\u20133","key":"527_CR177","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.trim.2013.12.003","volume":"30","author":"V Tiriveedhi","year":"2014","unstructured":"Tiriveedhi V, Upadhya GA, Busch RA, Gunter KL, Dines JN, Knolhoff BL, et al. Protective role of bortezomib in steatotic liver ischemia\/reperfusion injury through abrogation of MMP activation and YKL-40 expression. Transpl Immunol. 2014;30(2\u20133):93\u20138. https:\/\/doi.org\/10.1016\/j.trim.2013.12.003.","journal-title":"Transpl Immunol"},{"key":"527_CR178","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.bcp.2019.08.001","volume":"168","author":"MA Rabie","year":"2019","unstructured":"Rabie MA, Zaki HF, Sayed HM. Telluric acid ameliorates hepatic ischemia reperfusion-induced injury in rats: involvement of TLR4, Nrf2, and PI3K\/Akt signaling pathways. Biochem Pharmacol. 2019;168:404\u201311. https:\/\/doi.org\/10.1016\/j.bcp.2019.08.001.","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"527_CR179","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1177\/2050640619826847","volume":"7","author":"MM Sabry","year":"2019","unstructured":"Sabry MM, Ramadan NM, Al Dreny BA, Rashed LA, Abo El Enein A. Protective effect of apelin preconditioning in a rat model of hepatic ischemia reperfusion injury; possible interaction between the apelin\/APJ system, Ang II\/AT1R system and eNOS. United Eur Gastroenterol J. 2019;7(5):689\u201398. https:\/\/doi.org\/10.1177\/2050640619826847.","journal-title":"United Eur Gastroenterol J"},{"issue":"6","key":"527_CR180","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jhep.2019.01.019","volume":"70","author":"G Lassailly","year":"2019","unstructured":"Lassailly G, Bou Saleh M, Leleu-Chavain N, Ningarhari M, Gantier E, Carpentier R, et al. Nucleotide-binding oligomerization domain 1 (NOD1) modulates liver ischemia reperfusion through the expression adhesion molecules. J Hepatol. 2019;70(6):1159\u201369. https:\/\/doi.org\/10.1016\/j.jhep.2019.01.019.","journal-title":"J Hepatol"},{"issue":"2","key":"527_CR181","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1053\/jhep.2003.50063","volume":"37","author":"J Liu","year":"2003","unstructured":"Liu J, Li C, Waalkes MP, Clark J, Myers P, Saavedra JE, et al. The nitric oxide donor, V-PYRRO\/NO, protects against acetaminophen-induced hepatotoxicity in mice. Hepatology. 2003;37(2):324\u201333. https:\/\/doi.org\/10.1053\/jhep.2003.50063.","journal-title":"Hepatology"},{"issue":"1","key":"527_CR182","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/hep.30169","volume":"69","author":"X Wang","year":"2019","unstructured":"Wang X, Maretti-Mira AC, Wang L, DeLeve LD. Liver-selective MMP-9 inhibition in the rat eliminates ischemia-reperfusion injury and accelerates liver regeneration. Hepatology. 2019;69(1):314\u201328. https:\/\/doi.org\/10.1002\/hep.30169.","journal-title":"Hepatology"},{"issue":"5","key":"527_CR183","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1055\/a-2015-7976","volume":"73","author":"F Khajepour","year":"2023","unstructured":"Khajepour F, Mahmoodpoor F, Jafari E, Kakaei F, Bahraminia F, Aghajani S, et al. Prazosin protects the liver against renal Ischemia\/Reperfusion injury in rats. Drug Res (Stuttg). 2023;73(5):289\u201395. https:\/\/doi.org\/10.1055\/a-2015-7976.","journal-title":"Drug Res (Stuttg)"},{"issue":"3","key":"527_CR184","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/hep.23476","volume":"51","author":"H Yin","year":"2010","unstructured":"Yin H, Cheng L, Holt M, Hail N Jr, Maclaren R, Ju C. Lactoferrin protects against acetaminophen-induced liver injury in mice. Hepatology. 2010;51(3):1007\u201316. https:\/\/doi.org\/10.1002\/hep.23476.","journal-title":"Hepatology"},{"issue":"8","key":"527_CR185","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.3168\/jds.2023-24490","volume":"107","author":"S Guan","year":"2024","unstructured":"Guan S, Zhang S, Liu M, Guo J, Chen Y, Shen X, et al. Preventive effects of lactoferrin on acute alcohol-induced liver injury via iron chelation and regulation of iron metabolism. J Dairy Sci. 2024;107(8):5316\u201329. https:\/\/doi.org\/10.3168\/jds.2023-24490.","journal-title":"J Dairy Sci"},{"issue":"5","key":"527_CR186","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1016\/S2352-3026(23)00011-X","volume":"10","author":"SA Grupp","year":"2023","unstructured":"Grupp SA, Corbacioglu S, Kang HJ, Teshima T, Khaw SL, Locatelli F, et al. Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial. Lancet Haematol. 2023;10(5):e333\u201345. https:\/\/doi.org\/10.1016\/S2352-3026(23)00011-X.","journal-title":"Lancet Haematol"},{"issue":"4","key":"527_CR187","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1053\/jhep.2003.50383","volume":"38","author":"LD DeLeve","year":"2003","unstructured":"DeLeve LD, Wang X, Kanel GC, Ito Y, Bethea NW, McCuskey MK, et al. Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology. 2003;38(4):900\u20138. https:\/\/doi.org\/10.1053\/jhep.2003.50383.","journal-title":"Hepatology"},{"issue":"3","key":"527_CR188","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.21873\/invivo.11873","volume":"34","author":"S Kanou","year":"2020","unstructured":"Kanou S, Miyashita T, Yamamoto Y, Takada S, Nakura M, Okazaki M, et al. Prophylactic effect of recombinant human soluble thrombomodulin for hepatic sinusoidal obstruction syndrome model mice. In Vivo. 2020;34(3):1037\u201345. https:\/\/doi.org\/10.21873\/invivo.11873.","journal-title":"In Vivo"},{"key":"527_CR189","doi-asserted-by":"publisher","first-page":"114733","DOI":"10.1016\/j.taap.2019.114733","volume":"381","author":"F Otaka","year":"2019","unstructured":"Otaka F, Ito Y, Inoue T, Ohkubo H, Nishizawa N, Kojo K, et al. Thromboxane A(2) receptor signaling in endothelial cells attenuates monocrotaline-induced liver injury. Toxicol Appl Pharmacol. 2019;381:114733. https:\/\/doi.org\/10.1016\/j.taap.2019.114733.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"527_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/v15051203","volume":"15","author":"S Schefczyk","year":"2023","unstructured":"Schefczyk S, Luo X, Liang Y, Trippler M, Lu M, Wedemeyer H, et al. Poly(I:C) induces distinct liver cell type-specific responses in hepatitis B virus-transgenic mice in vitro, but fails to induce these signals in vivo. Viruses. 2023;15(5):1203. https:\/\/doi.org\/10.3390\/v15051203.","journal-title":"Viruses"},{"issue":"11","key":"527_CR191","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1136\/gutjnl-2017-315588","volume":"68","author":"HJ Zhao","year":"2019","unstructured":"Zhao HJ, Han QJ, Wang G, Lin A, Xu DQ, Wang YQ, et al. Poly(I:C)-based rHBVvac therapeutic vaccine eliminates HBV via generation of HBV-specific CD8(+) effector memory T cells. Gut. 2019;68(11):2032\u201343. https:\/\/doi.org\/10.1136\/gutjnl-2017-315588.","journal-title":"Gut"},{"key":"527_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01495","volume":"9","author":"Y Lin","year":"2018","unstructured":"Lin Y, Huang X, Wu J, Liu J, Chen M, Ma Z, et al. Pre-activation of Toll-like receptor 2 enhances CD8(+) T-cell responses and accelerates hepatitis B virus clearance in the mouse models. Front Immunol. 2018;9:1495. https:\/\/doi.org\/10.3389\/fimmu.2018.01495.","journal-title":"Front Immunol"},{"issue":"10","key":"527_CR193","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.3390\/pharmaceutics15102463","volume":"15","author":"M Gil","year":"2023","unstructured":"Gil M, Khouri L, Raurell I, Rafael D, Andrade F, Abasolo I, et al. Optimization of statin-loaded delivery nanoparticles for treating chronic liver diseases by targeting liver sinusoidal endothelial cells. Pharmaceutics. 2023;15(10):2463. https:\/\/doi.org\/10.3390\/pharmaceutics15102463.","journal-title":"Pharmaceutics"},{"issue":"1","key":"527_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07213-x","volume":"9","author":"M Welz","year":"2018","unstructured":"Welz M, Eickhoff S, Abdullah Z, Trebicka J, Gartlan KH, Spicer JA, et al. Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis. Nat Commun. 2018;9(1):4805. https:\/\/doi.org\/10.1038\/s41467-018-07213-x.","journal-title":"Nat Commun"},{"issue":"Suppl 1","key":"527_CR195","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12072-017-9833-y","volume":"12","author":"A Baiges","year":"2018","unstructured":"Baiges A, Hernandez-Gea V, Bosch J. Pharmacologic prevention of variceal bleeding and rebleeding. Hepatol Int. 2018;12(Suppl 1):68\u201380. https:\/\/doi.org\/10.1007\/s12072-017-9833-y.","journal-title":"Hepatol Int"},{"issue":"9","key":"527_CR196","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","volume":"64","author":"G Marrone","year":"2015","unstructured":"Marrone G, Maeso-Diaz R, Garcia-Cardena G, Abraldes JG, Garcia-Pagan JC, Bosch J, et al. KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins. Gut. 2015;64(9):1434\u201343. https:\/\/doi.org\/10.1136\/gutjnl-2014-308338.","journal-title":"Gut"},{"issue":"5","key":"527_CR197","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1053\/j.gastro.2009.01.043","volume":"136","author":"JG Abraldes","year":"2009","unstructured":"Abraldes JG, Albillos A, Banares R, Turnes J, Gonzalez R, Garcia-Pagan JC, et al. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology. 2009;136(5):1651\u20138. https:\/\/doi.org\/10.1053\/j.gastro.2009.01.043.","journal-title":"Gastroenterology"},{"issue":"13","key":"527_CR198","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18529","volume":"28","author":"S Parsa","year":"2024","unstructured":"Parsa S, Dousti M, Mohammadi N, Abedanzadeh M, Dehdari Ebrahimi N, Dara M, et al. The effects of simvastatin-loaded nanoliposomes on human multilineage liver fibrosis microtissue. J Cell Mol Med. 2024;28(13):e18529. https:\/\/doi.org\/10.1111\/jcmm.18529.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"527_CR199","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179809","volume":"12","author":"CC Chang","year":"2017","unstructured":"Chang CC, Lee WS, Hsieh HG, Chuang CL, Huang HC, Lee FY, et al. Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats. PLoS ONE. 2017;12(6):e0179809. https:\/\/doi.org\/10.1371\/journal.pone.0179809.","journal-title":"PLoS ONE"},{"issue":"2","key":"527_CR200","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jhep.2008.04.014","volume":"49","author":"V Matei","year":"2008","unstructured":"Matei V, Rodriguez-Vilarrupla A, Deulofeu R, Garcia-Caldero H, Fernandez M, Bosch J, et al. Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats. J Hepatol. 2008;49(2):192\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2008.04.014.","journal-title":"J Hepatol"},{"issue":"1","key":"527_CR201","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep.21228","volume":"44","author":"V Matei","year":"2006","unstructured":"Matei V, Rodriguez-Vilarrupla A, Deulofeu R, Colomer D, Fernandez M, Bosch J, et al. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis. Hepatology. 2006;44(1):44\u201352. https:\/\/doi.org\/10.1002\/hep.21228.","journal-title":"Hepatology"},{"issue":"7","key":"527_CR202","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1042\/CS20090536","volume":"119","author":"FE Xavier","year":"2010","unstructured":"Xavier FE, Blanco-Rivero J, Sastre E, Badimon L, Balfagon G. Simultaneous inhibition of TXA(2) and PGI(2) synthesis increases NO release in mesenteric resistance arteries from cirrhotic rats. Clin Sci (Lond). 2010;119(7):283\u201392. https:\/\/doi.org\/10.1042\/CS20090536.","journal-title":"Clin Sci (Lond)"},{"issue":"9","key":"527_CR203","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/j.1478-3231.2009.02093.x","volume":"29","author":"M Luna","year":"2009","unstructured":"Luna M, Karavitakis M. Treating portal hypertension in cirrhotic rats with AVE 9488. Liver Int. 2009;29(9):1448. https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02093.x.","journal-title":"Liver Int"},{"issue":"3","key":"527_CR204","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1478-3231.2008.01664.x","volume":"28","author":"E Biecker","year":"2008","unstructured":"Biecker E, Trebicka J, Kang A, Hennenberg M, Sauerbruch T, Heller J. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension. Liver Int. 2008;28(3):331\u20138. https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01664.x.","journal-title":"Liver Int"},{"issue":"3","key":"527_CR205","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3945\/ajcn.112.040469","volume":"96","author":"A De Gottardi","year":"2012","unstructured":"De Gottardi A, Berzigotti A, Seijo S, D\u2019Amico M, Thormann W, Abraldes JG, et al. Postprandial effects of dark chocolate on portal hypertension in patients with cirrhosis: results of a phase 2, double-blind, randomized controlled trial. Am J Clin Nutr. 2012;96(3):584\u201390. https:\/\/doi.org\/10.3945\/ajcn.112.040469.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"527_CR206","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jhep.2011.12.008","volume":"56","author":"A Rodriguez-Vilarrupla","year":"2012","unstructured":"Rodriguez-Vilarrupla A, Lavina B, Garcia-Caldero H, Russo L, Rosado E, Roglans N, et al. PPARalpha activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats. J Hepatol. 2012;56(5):1033\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2011.12.008.","journal-title":"J Hepatol"},{"issue":"1","key":"527_CR207","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jhep.2008.02.012","volume":"49","author":"YY Yang","year":"2008","unstructured":"Yang YY, Lee KC, Huang YT, Wang YW, Hou MC, Lee FY, et al. Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis. J Hepatol. 2008;49(1):25\u201333. https:\/\/doi.org\/10.1016\/j.jhep.2008.02.012.","journal-title":"J Hepatol"},{"issue":"2","key":"527_CR208","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4062\/biomolther.2021.062","volume":"30","author":"E Olaso","year":"2022","unstructured":"Olaso E, Benedicto A, Lopategi A, Cossio FP, Arteta B. A synthetic analog of resveratrol inhibits the proangiogenic response of liver sinusoidal cells during hepatic metastasis. Biomol Ther (Seoul). 2022;30(2):162\u20139. https:\/\/doi.org\/10.4062\/biomolther.2021.062.","journal-title":"Biomol Ther (Seoul)"},{"key":"527_CR209","doi-asserted-by":"publisher","first-page":"33453","DOI":"10.1038\/srep33453","volume":"6","author":"L Verbeke","year":"2016","unstructured":"Verbeke L, Mannaerts I, Schierwagen R, Govaere O, Klein S, Vander Elst I, et al. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Sci Rep. 2016;6:33453. https:\/\/doi.org\/10.1038\/srep33453.","journal-title":"Sci Rep"},{"key":"527_CR210","doi-asserted-by":"publisher","DOI":"10.1038\/srep40461","volume":"7","author":"S Rodriguez","year":"2017","unstructured":"Rodriguez S, Raurell I, Torres-Arauz M, Garcia-Lezana T, Genesca J, Martell M. A nitric oxide-donating statin decreases portal pressure with a better toxicity profile than conventional statins in cirrhotic rats. Sci Rep. 2017;7:40461. https:\/\/doi.org\/10.1038\/srep40461.","journal-title":"Sci Rep"},{"issue":"7","key":"527_CR211","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.nano.2017.06.019","volume":"13","author":"L Lin","year":"2017","unstructured":"Lin L, Cai M, Deng S, Huang W, Huang J, Huang X, et al. Amelioration of cirrhotic portal hypertension by targeted cyclooxygenase-1 siRNA delivery to liver sinusoidal endothelium with polyethylenimine grafted hyaluronic acid. Nanomedicine. 2017;13(7):2329\u201339. https:\/\/doi.org\/10.1016\/j.nano.2017.06.019.","journal-title":"Nanomedicine"},{"issue":"4","key":"527_CR212","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jhep.2016.12.005","volume":"66","author":"P Schwabl","year":"2017","unstructured":"Schwabl P, Hambruch E, Seeland BA, Hayden H, Wagner M, Garnys L, et al. The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction. J Hepatol. 2017;66(4):724\u201333. https:\/\/doi.org\/10.1016\/j.jhep.2016.12.005.","journal-title":"J Hepatol"},{"issue":"10","key":"527_CR213","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1111\/liv.14610","volume":"40","author":"G Pietrosi","year":"2020","unstructured":"Pietrosi G, Fernandez-Iglesias A, Pampalone M, Ortega-Ribera M, Lozano JJ, Garcia-Caldero H, et al. Human amniotic stem cells improve hepatic microvascular dysfunction and portal hypertension in cirrhotic rats. Liver Int. 2020;40(10):2500\u201314. https:\/\/doi.org\/10.1111\/liv.14610.","journal-title":"Liver Int"},{"issue":"7","key":"527_CR214","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ajpath.2018.03.018","volume":"188","author":"HC Tsai","year":"2018","unstructured":"Tsai HC, Li TH, Huang CC, Huang SF, Liu RS, Yang YY, et al. Beneficial effects of the peroxisome proliferator-activated receptor alpha\/gamma agonist aleglitazar on progressive hepatic and splanchnic abnormalities in cirrhotic rats with portal hypertension. Am J Pathol. 2018;188(7):1608\u201324. https:\/\/doi.org\/10.1016\/j.ajpath.2018.03.018.","journal-title":"Am J Pathol"},{"issue":"5","key":"527_CR215","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.jhep.2020.11.045","volume":"74","author":"Z Boyer-Diaz","year":"2021","unstructured":"Boyer-Diaz Z, Aristu-Zabalza P, Andres-Rozas M, Robert C, Ortega-Ribera M, Fernandez-Iglesias A, et al. Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease. J Hepatol. 2021;74(5):1188\u201399. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.045.","journal-title":"J Hepatol"},{"issue":"3","key":"527_CR216","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00109-019-01746-4","volume":"97","author":"L Hu","year":"2019","unstructured":"Hu L, Su L, Dong Z, Wu Y, Lv Y, George J, et al. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model. J Mol Med (Berl). 2019;97(3):423\u201334. https:\/\/doi.org\/10.1007\/s00109-019-01746-4.","journal-title":"J Mol Med (Berl)"},{"issue":"7","key":"527_CR217","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/hep4.1360","volume":"3","author":"J Gracia-Sancho","year":"2019","unstructured":"Gracia-Sancho J, Manicardi N, Ortega-Ribera M, Maeso-Diaz R, Guixe-Muntet S, Fernandez-Iglesias A, et al. Emricasan ameliorates portal hypertension and liver fibrosis in cirrhotic rats through a hepatocyte-mediated paracrine mechanism. Hepatol Commun. 2019;3(7):987\u20131000. https:\/\/doi.org\/10.1002\/hep4.1360.","journal-title":"Hepatol Commun"},{"issue":"3","key":"527_CR218","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s11684-019-0689-5","volume":"13","author":"R Zhang","year":"2019","unstructured":"Zhang R, Chen J, Liu D, Wang Y. Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl(4)-induced cirrhotic rats. Front Med. 2019;13(3):398\u2013408. https:\/\/doi.org\/10.1007\/s11684-019-0689-5.","journal-title":"Front Med"},{"issue":"5","key":"527_CR219","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1053\/j.gastro.2018.07.022","volume":"155","author":"DM Tripathi","year":"2018","unstructured":"Tripathi DM, Vilaseca M, Lafoz E, Garcia-Caldero H, Viegas Haute G, Fernandez-Iglesias A, et al. Simvastatin prevents progression of acute on chronic liver failure in rats with cirrhosis and portal hypertension. Gastroenterology. 2018;155(5):1564\u201377. https:\/\/doi.org\/10.1053\/j.gastro.2018.07.022.","journal-title":"Gastroenterology"},{"issue":"5","key":"527_CR220","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/hep4.1881","volume":"6","author":"E Pose","year":"2022","unstructured":"Pose E, Sola E, Lozano JJ, Juanola A, Sidorova J, Zaccherini G, et al. Treatment with simvastatin and rifaximin restores the plasma metabolomic profile in patients with decompensated cirrhosis. Hepatol Commun. 2022;6(5):1100\u201312. https:\/\/doi.org\/10.1002\/hep4.1881.","journal-title":"Hepatol Commun"},{"issue":"1","key":"527_CR221","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12951-021-01205-8","volume":"20","author":"Z Yu","year":"2022","unstructured":"Yu Z, Guo J, Liu Y, Wang M, Liu Z, Gao Y, et al. Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma. J Nanobiotechnology. 2022;20(1):9. https:\/\/doi.org\/10.1186\/s12951-021-01205-8.","journal-title":"J Nanobiotechnology"},{"issue":"3","key":"527_CR222","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s12072-023-10572-3","volume":"18","author":"T Tanaka","year":"2024","unstructured":"Tanaka T, Koga H, Suzuki H, Iwamoto H, Sakaue T, Masuda A, et al. Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1-AXL signal relay in liver cancer cells. Hepatol Int. 2024;18(3):984\u201397. https:\/\/doi.org\/10.1007\/s12072-023-10572-3.","journal-title":"Hepatol Int"},{"issue":"3","key":"527_CR223","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jhep.2016.10.029","volume":"66","author":"AG Duffy","year":"2017","unstructured":"Duffy AG, Ulahannan SV, Makorova-Rusher O, Rahma O, Wedemeyer H, Pratt D, et al. Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. J Hepatol. 2017;66(3):545\u201351. https:\/\/doi.org\/10.1016\/j.jhep.2016.10.029.","journal-title":"J Hepatol"},{"issue":"10064","key":"527_CR224","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","volume":"389","author":"J Bruix","year":"2017","unstructured":"Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;389(10064):56\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(16)32453-9.","journal-title":"Lancet"},{"issue":"9","key":"527_CR225","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s43018-021-00234-4","volume":"2","author":"WJ Ho","year":"2021","unstructured":"Ho WJ, Zhu Q, Durham J, Popovic A, Xavier S, Leatherman J, et al. Neoadjuvant cabozantinib and nivolumab converts locally advanced HCC into resectable disease with enhanced antitumor immunity. Nat Cancer. 2021;2(9):891\u2013903. https:\/\/doi.org\/10.1038\/s43018-021-00234-4.","journal-title":"Nat Cancer"},{"issue":"3","key":"527_CR226","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.bbrc.2015.07.057","volume":"464","author":"W Li","year":"2015","unstructured":"Li W, Shen S, Wu S, Chen Z, Hu C, Yan R. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism. Biochem Biophys Res Commun. 2015;464(3):881\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.057.","journal-title":"Biochem Biophys Res Commun"},{"key":"527_CR227","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-pathmechdis-051122-094016","volume":"19","author":"H Jaeschke","year":"2024","unstructured":"Jaeschke H, Ramachandran A. Acetaminophen hepatotoxicity: paradigm for understanding mechanisms of drug-induced liver injury. Annu Rev Pathol. 2024;19:453\u201378. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-051122-094016.","journal-title":"Annu Rev Pathol"},{"key":"527_CR228","doi-asserted-by":"publisher","first-page":"828565","DOI":"10.3389\/fphar.2022.828565","volume":"13","author":"A Licata","year":"2022","unstructured":"Licata A, Minissale MG, Stankeviciute S, Sanabria-Cabrera J, Lucena MI, Andrade RJ, et al. N-Acetylcysteine for preventing acetaminophen-induced liver injury: a comprehensive review. Front Pharmacol. 2022;13:828565. https:\/\/doi.org\/10.3389\/fphar.2022.828565.","journal-title":"Front Pharmacol"},{"issue":"41","key":"527_CR229","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.18632\/oncotarget.26937","volume":"10","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Jiang L, Yu J, Tian L, Guo T, Di B, et al. Palmitate up-regulates laminin expression via ROS\/integrin alphavbeta3 pathway in hlsecs. Oncotarget. 2019;10(41):4083\u201390. https:\/\/doi.org\/10.18632\/oncotarget.26937.","journal-title":"Oncotarget"},{"issue":"2","key":"527_CR230","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/jphp.12501","volume":"68","author":"LF Granados-Castro","year":"2016","unstructured":"Granados-Castro LF, Rodriguez-Rangel DS, Fernandez-Rojas B, Leon-Contreras JC, Hernandez-Pando R, Medina-Campos ON, et al. Curcumin prevents paracetamol-induced liver mitochondrial alterations. J Pharm Pharmacol. 2016;68(2):245\u201356. https:\/\/doi.org\/10.1111\/jphp.12501.","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"527_CR231","doi-asserted-by":"publisher","first-page":"569","DOI":"10.21873\/invivo.11809","volume":"34","author":"G Dogaru","year":"2020","unstructured":"Dogaru G, Bulboaca AE, Gheban D, Boarescu PM, Rus V, Festila D, et al. Effect of liposomal curcumin on acetaminophen hepatotoxicity by down-regulation of oxidative stress and matrix metalloproteinases. In Vivo. 2020;34(2):569\u201382. https:\/\/doi.org\/10.21873\/invivo.11809.","journal-title":"In Vivo"},{"key":"527_CR232","doi-asserted-by":"publisher","first-page":"143966","DOI":"10.1016\/j.gene.2019.143966","volume":"712","author":"MM Ahmad","year":"2019","unstructured":"Ahmad MM, Rezk NA, Fawzy A, Sabry M. Protective effects of curcumin and silymarin against paracetamol induced hepatotoxicity in adult male albino rats. Gene. 2019;712:143966. https:\/\/doi.org\/10.1016\/j.gene.2019.143966.","journal-title":"Gene"},{"issue":"5","key":"527_CR233","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/medicina55050181","volume":"55","author":"AM Abdulrazzaq","year":"2019","unstructured":"Abdulrazzaq AM, Badr M, Gammoh O, Abu Khalil AA, Ghanim BY, Alhussainy TM, et al. Hepatoprotective actions of ascorbic acid, alpha lipoic acid and silymarin or their combination against acetaminophen-induced hepatotoxicity in rats. Medicina (Kaunas). 2019;55(5):181. https:\/\/doi.org\/10.3390\/medicina55050181.","journal-title":"Medicina (Kaunas)"},{"key":"527_CR234","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.fct.2015.03.020","volume":"80","author":"JR Noh","year":"2015","unstructured":"Noh JR, Kim YH, Hwang JH, Choi DH, Kim KS, Oh WK, et al. Sulforaphane protects against acetaminophen-induced hepatotoxicity. Food Chem Toxicol. 2015;80:193\u2013200. https:\/\/doi.org\/10.1016\/j.fct.2015.03.020.","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"527_CR235","doi-asserted-by":"publisher","first-page":"64","DOI":"10.21315\/mjms2018.25.2.7","volume":"25","author":"A Hamid","year":"2018","unstructured":"Hamid A, Lee LS, Karim SR, Jufri NF. Hepatoprotective effects of zerumbone against paracetamol-induced acute hepatotoxicity in rats. Malays J Med Sci. 2018;25(2):64\u201371. https:\/\/doi.org\/10.21315\/mjms2018.25.2.7.","journal-title":"Malays J Med Sci"},{"issue":"1","key":"527_CR236","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/ptr.1084","volume":"17","author":"BH Ali","year":"2003","unstructured":"Ali BH, Mousa HM, El-Mougy S. The effect of a water extract and anthocyanins of Hibiscus sabdariffa L. on paracetamol-induced hepatoxicity in rats. Phytother Res. 2003;17(1):56\u20139. https:\/\/doi.org\/10.1002\/ptr.1084.","journal-title":"Phytother Res"},{"issue":"1","key":"527_CR237","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/13880209.2016.1246575","volume":"55","author":"EA Abd El-Ghffar","year":"2017","unstructured":"Abd El-Ghffar EA, El-Nashar HA, Eldahshan OA, Singab AN. GC-MS analysis and hepatoprotective activity of the n-hexane extract of Acrocarpus fraxinifolius leaves against paracetamol-induced hepatotoxicity in male albino rats. Pharm Biol. 2017;55(1):441\u20139. https:\/\/doi.org\/10.1080\/13880209.2016.1246575.","journal-title":"Pharm Biol"},{"issue":"5","key":"527_CR238","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/0148607110362584","volume":"34","author":"VR Chandrasekaran","year":"2010","unstructured":"Chandrasekaran VR, Chien SP, Hsu DZ, Chang YC, Liu MY. Effects of sesame oil against after the onset of acetaminophen-induced acute hepatic injury in rats. JPEN J Parenter Enteral Nutr. 2010;34(5):567\u201373. https:\/\/doi.org\/10.1177\/0148607110362584.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"2","key":"527_CR239","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/13880209.2014.913066","volume":"53","author":"EM El Morsy","year":"2015","unstructured":"El Morsy EM, Kamel R. Protective effect of artichoke leaf extract against paracetamol-induced hepatotoxicity in rats. Pharm Biol. 2015;53(2):167\u201373. https:\/\/doi.org\/10.3109\/13880209.2014.913066.","journal-title":"Pharm Biol"},{"key":"527_CR240","doi-asserted-by":"publisher","first-page":"1122632","DOI":"10.3389\/fphar.2023.1122632","volume":"14","author":"J Liao","year":"2023","unstructured":"Liao J, Lu Q, Li Z, Li J, Zhao Q, Li J. Acetaminophen-induced liver injury: molecular mechanism and treatments from natural products. Front Pharmacol. 2023;14:1122632. https:\/\/doi.org\/10.3389\/fphar.2023.1122632.","journal-title":"Front Pharmacol"},{"issue":"23","key":"527_CR241","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28237901","volume":"28","author":"X Li","year":"2023","unstructured":"Li X, Lao R, Lei J, Chen Y, Zhou Q, Wang T, et al. Natural products for acetaminophen-induced acute liver injury: a review. Molecules. 2023;28(23):7901. https:\/\/doi.org\/10.3390\/molecules28237901.","journal-title":"Molecules"},{"issue":"6","key":"527_CR242","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.3390\/ijms24065620","volume":"24","author":"I Mavrikou","year":"2023","unstructured":"Mavrikou I, Chatzidimitriou D, Skoura L, Nikolousis E, Sakellari I, Gavriilaki E. Molecular advances in sinusoidal obstruction Syndrome\/Veno-Occlusive disease. Int J Mol Sci. 2023;24(6):5620. https:\/\/doi.org\/10.3390\/ijms24065620.","journal-title":"Int J Mol Sci"},{"key":"527_CR243","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3389\/fimmu.2020.00489","volume":"11","author":"F Bonifazi","year":"2020","unstructured":"Bonifazi F, Barbato F, Ravaioli F, Sessa M, Defrancesco I, Arpinati M, et al. Diagnosis and treatment of VOD\/SOS after allogeneic hematopoietic stem cell transplantation. Front Immunol. 2020;11:489. https:\/\/doi.org\/10.3389\/fimmu.2020.00489.","journal-title":"Front Immunol"},{"issue":"4","key":"527_CR244","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ajpath.2017.12.007","volume":"188","author":"S Oda","year":"2018","unstructured":"Oda S, Takeuchi M, Akai S, Shirai Y, Tsuneyama K, Yokoi T. miRNA in rat liver sinusoidal endothelial cells and hepatocytes and application to circulating biomarkers that discern pathogenesis of liver injuries. Am J Pathol. 2018;188(4):916\u201328. https:\/\/doi.org\/10.1016\/j.ajpath.2017.12.007.","journal-title":"Am J Pathol"},{"issue":"5","key":"527_CR245","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41409-018-0304-4","volume":"54","author":"K Yakushijin","year":"2019","unstructured":"Yakushijin K, Ikezoe T, Ohwada C, Kudo K, Okamura H, Goto H, et al. Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2019;54(5):674\u201380. https:\/\/doi.org\/10.1038\/s41409-018-0304-4.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"527_CR246","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hep.28813","volume":"65","author":"VJ Navarro","year":"2017","unstructured":"Navarro VJ, Khan I, Bjornsson E, Seeff LB, Serrano J, Hoofnagle JH. Liver injury from herbal and dietary supplements. Hepatology. 2017;65(1):363\u201373. https:\/\/doi.org\/10.1002\/hep.28813.","journal-title":"Hepatology"},{"issue":"10","key":"527_CR247","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19102955","volume":"19","author":"J Zhu","year":"2018","unstructured":"Zhu J, Seo JE, Wang S, Ashby K, Ballard R, Yu D, et al. The development of a database for herbal and dietary supplement induced liver toxicity. Int J Mol Sci. 2018;19(10):2955. https:\/\/doi.org\/10.3390\/ijms19102955.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"527_CR248","doi-asserted-by":"publisher","first-page":"e16071","DOI":"10.1111\/liv.16071","volume":"45","author":"D Halegoua-DeMarzio","year":"2025","unstructured":"Halegoua-DeMarzio D, Navarro V. Challenges in herbal-induced liver injury identification and prevention. Liver Int. 2025;45(3):e16071. https:\/\/doi.org\/10.1111\/liv.16071.","journal-title":"Liver Int"},{"issue":"12","key":"527_CR249","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/82161","volume":"6","author":"A Limmer","year":"2000","unstructured":"Limmer A, Ohl J, Kurts C, Ljunggren HG, Reiss Y, Groettrup M, et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med. 2000;6(12):1348\u201354. https:\/\/doi.org\/10.1038\/82161.","journal-title":"Nat Med"},{"key":"527_CR250","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.molimm.2018.06.002","volume":"101","author":"S Huang","year":"2018","unstructured":"Huang S, Wu J, Gao X, Zou S, Chen L, Yang X, et al. LSECs express functional NOD1 receptors: a role for NOD1 in LSEC maturation-induced T cell immunity in vitro. Mol Immunol. 2018;101:167\u201375. https:\/\/doi.org\/10.1016\/j.molimm.2018.06.002.","journal-title":"Mol Immunol"},{"issue":"6","key":"527_CR251","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/liv.12182","volume":"33","author":"C Tuncer","year":"2013","unstructured":"Tuncer C, Oo YH, Murphy N, Adams DH, Lalor PF. The regulation of T-cell recruitment to the human liver during acute liver failure. Liver Int. 2013;33(6):852\u201363. https:\/\/doi.org\/10.1111\/liv.12182.","journal-title":"Liver Int"},{"issue":"10","key":"527_CR252","doi-asserted-by":"publisher","first-page":"e0206756","DOI":"10.1371\/journal.pone.0206756","volume":"13","author":"J Falero-Perez","year":"2018","unstructured":"Falero-Perez J, Song YS, Zhao Y, Teixeira L, Sorenson CM, Sheibani N. Cyp1b1 expression impacts the angiogenic and inflammatory properties of liver sinusoidal endothelial cells. PLoS ONE. 2018;13(10):e0206756. https:\/\/doi.org\/10.1371\/journal.pone.0206756.","journal-title":"PLoS ONE"},{"issue":"5","key":"527_CR253","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jhep.2005.09.020","volume":"44","author":"M Martin-Armas","year":"2006","unstructured":"Martin-Armas M, Simon-Santamaria J, Pettersen I, Moens U, Smedsrod B, Sveinbjornsson B. Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides. J Hepatol. 2006;44(5):939\u201346. https:\/\/doi.org\/10.1016\/j.jhep.2005.09.020.","journal-title":"J Hepatol"},{"issue":"7","key":"527_CR254","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3109\/00313020903257764","volume":"41","author":"R Cheluvappa","year":"2009","unstructured":"Cheluvappa R, Denning GM, Lau GW, Grimm MC, Hilmer SN, Le Couteur DG. Pseudomonas aeruginosa and the hyperlipidaemia of sepsis. Pathology. 2009;41(7):615\u201321. https:\/\/doi.org\/10.3109\/00313020903257764.","journal-title":"Pathology"},{"issue":"10","key":"527_CR255","doi-asserted-by":"publisher","first-page":"e857","DOI":"10.1016\/j.ijid.2010.02.2263","volume":"14","author":"R Cheluvappa","year":"2010","unstructured":"Cheluvappa R, Denning GM, Lau GW, Grimm MC, Hilmer SN, Le Couteur DG. Pathogenesis of the hyperlipidemia of gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells. Int J Infect Dis. 2010;14(10):e857\u201367. https:\/\/doi.org\/10.1016\/j.ijid.2010.02.2263.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"527_CR256","doi-asserted-by":"publisher","first-page":"e97701","DOI":"10.1371\/journal.pone.0097701","volume":"9","author":"K Heesch","year":"2014","unstructured":"Heesch K, Raczkowski F, Schumacher V, Hunemorder S, Panzer U, Mittrucker HW. The function of the chemokine receptor CXCR6 in the T cell response of mice against Listeria monocytogenes. PLoS ONE. 2014;9(5):e97701. https:\/\/doi.org\/10.1371\/journal.pone.0097701.","journal-title":"PLoS ONE"},{"issue":"12","key":"527_CR257","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.4049\/jimmunol.1301262","volume":"191","author":"J Liu","year":"2013","unstructured":"Liu J, Jiang M, Ma Z, Dietze KK, Zelinskyy G, Yang D, et al. TLR1\/2 ligand-stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in vitro. J Immunol. 2013;191(12):6178\u201390. https:\/\/doi.org\/10.4049\/jimmunol.1301262.","journal-title":"J Immunol"},{"issue":"18","key":"527_CR258","doi-asserted-by":"publisher","first-page":"10421","DOI":"10.1128\/JVI.00996-14","volume":"88","author":"J Wu","year":"2014","unstructured":"Wu J, Huang S, Zhao X, Chen M, Lin Y, Xia Y, et al. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model. J Virol. 2014;88(18):10421\u201331. https:\/\/doi.org\/10.1128\/JVI.00996-14.","journal-title":"J Virol"},{"issue":"31","key":"527_CR259","doi-asserted-by":"publisher","first-page":"32035","DOI":"10.1074\/jbc.M402296200","volume":"279","author":"PY Lozach","year":"2004","unstructured":"Lozach PY, Amara A, Bartosch B, Virelizier JL, Arenzana-Seisdedos F, Cosset FL, et al. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J Biol Chem. 2004;279(31):32035\u201345. https:\/\/doi.org\/10.1074\/jbc.M402296200.","journal-title":"J Biol Chem"},{"issue":"5","key":"527_CR260","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/jmv.25034","volume":"90","author":"LJ Sun","year":"2018","unstructured":"Sun LJ, Yu JW, Shi YG, Zhang XY, Shu MN, Chen MY. Hepatitis C virus core protein induces dysfunction of liver sinusoidal endothelial cell by down-regulation of silent information regulator 1. J Med Virol. 2018;90(5):926\u201335. https:\/\/doi.org\/10.1002\/jmv.25034.","journal-title":"J Med Virol"},{"issue":"17","key":"527_CR261","doi-asserted-by":"publisher","first-page":"8869","DOI":"10.1128\/JVI.00870-09","volume":"83","author":"CK Seckert","year":"2009","unstructured":"Seckert CK, Renzaho A, Tervo HM, Krause C, Deegen P, Kuhnapfel B, et al. Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation. J Virol. 2009;83(17):8869\u201384. https:\/\/doi.org\/10.1128\/JVI.00870-09.","journal-title":"J Virol"},{"issue":"5","key":"527_CR262","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.chom.2007.10.002","volume":"2","author":"A Coppi","year":"2007","unstructured":"Coppi A, Tewari R, Bishop JR, Bennett BL, Lawrence R, Esko JD, et al. Heparan sulfate proteoglycans provide a signal to Plasmodium sporozoites to stop migrating and productively invade host cells. Cell Host Microbe. 2007;2(5):316\u201327. https:\/\/doi.org\/10.1016\/j.chom.2007.10.002.","journal-title":"Cell Host Microbe"},{"issue":"5","key":"527_CR263","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1136\/gutjnl-2019-318237","volume":"69","author":"J Bosch","year":"2020","unstructured":"Bosch J, Gracia-Sancho J, Abraldes JG. Cirrhosis as new indication for statins. Gut. 2020;69(5):953\u201362. https:\/\/doi.org\/10.1136\/gutjnl-2019-318237.","journal-title":"Gut"},{"key":"527_CR264","doi-asserted-by":"publisher","first-page":"120966","DOI":"10.1016\/j.lfs.2022.120966","volume":"308","author":"Q Niaz","year":"2022","unstructured":"Niaz Q, Tavangar SM, Mehreen S, Ghazi-Khansari M, Jazaeri F. Evaluation of statins as a new therapy to alleviate chronotropic dysfunction in cirrhotic rats. Life Sci. 2022;308:120966. https:\/\/doi.org\/10.1016\/j.lfs.2022.120966.","journal-title":"Life Sci"},{"issue":"4","key":"527_CR265","doi-asserted-by":"publisher","first-page":"684","DOI":"10.14336\/AD.2019.0127","volume":"10","author":"R Maeso-Diaz","year":"2019","unstructured":"Maeso-Diaz R, Ortega-Ribera M, Lafoz E, Lozano JJ, Baiges A, Frances R, et al. Aging influences hepatic microvascular biology and liver fibrosis in advanced chronic liver disease. Aging Dis. 2019;10(4):684\u201398. https:\/\/doi.org\/10.14336\/AD.2019.0127.","journal-title":"Aging Dis"},{"key":"527_CR266","doi-asserted-by":"publisher","first-page":"102267","DOI":"10.1016\/j.nano.2020.102267","volume":"29","author":"D Hide","year":"2020","unstructured":"Hide D, Gil M, Andrade F, Rafael D, Raurell I, Bravo M, et al. Simvastatin-loaded polymeric micelles are more effective and less toxic than conventional statins in a pre-clinical model of advanced chronic liver disease. Nanomedicine. 2020;29:102267. https:\/\/doi.org\/10.1016\/j.nano.2020.102267.","journal-title":"Nanomedicine"},{"issue":"3","key":"527_CR267","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1053\/j.gastro.2003.12.007","volume":"126","author":"C Zafra","year":"2004","unstructured":"Zafra C, Abraldes JG, Turnes J, Berzigotti A, Fernandez M, Garcia-Pagan JC, et al. Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis. Gastroenterology. 2004;126(3):749\u201355. https:\/\/doi.org\/10.1053\/j.gastro.2003.12.007.","journal-title":"Gastroenterology"},{"issue":"6","key":"527_CR268","doi-asserted-by":"publisher","first-page":"100740","DOI":"10.1016\/j.jhepr.2023.100740","volume":"5","author":"S Chapin","year":"2023","unstructured":"Chapin S, Kaplan DE, Taddei T, Mahmud N. Association between statin exposure and short-term mortality in patients with high-grade acute-on-chronic liver failure. JHEP Rep. 2023;5(6):100740. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100740.","journal-title":"JHEP Rep"},{"issue":"2","key":"527_CR269","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12072-015-9613-5","volume":"9","author":"J Gracia-Sancho","year":"2015","unstructured":"Gracia-Sancho J, Maeso-Diaz R, Fernandez-Iglesias A, Navarro-Zornoza M, Bosch J. New cellular and molecular targets for the treatment of portal hypertension. Hepatol Int. 2015;9(2):183\u201391. https:\/\/doi.org\/10.1007\/s12072-015-9613-5.","journal-title":"Hepatol Int"},{"issue":"15","key":"527_CR270","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1073\/pnas.1613392114","volume":"114","author":"Y Manavski","year":"2017","unstructured":"Manavski Y, Abel T, Hu J, Kleinlutzum D, Buchholz CJ, Belz C, et al. Endothelial transcription factor KLF2 negatively regulates liver regeneration via induction of activin a. Proc Natl Acad Sci U S A. 2017;114(15):3993\u20138. https:\/\/doi.org\/10.1073\/pnas.1613392114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"527_CR271","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/hep.26939","volume":"59","author":"L Verbeke","year":"2014","unstructured":"Verbeke L, Farre R, Trebicka J, Komuta M, Roskams T, Klein S, et al. Obeticholic acid, a farnesoid x receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. Hepatology. 2014;59(6):2286\u201398. https:\/\/doi.org\/10.1002\/hep.26939.","journal-title":"Hepatology"},{"issue":"11","key":"527_CR272","doi-asserted-by":"publisher","first-page":"100576","DOI":"10.1016\/j.jhepr.2022.100576","volume":"4","author":"MTA de Beijer","year":"2022","unstructured":"de Beijer MTA, Bezstarosti K, Luijten R, Doff WAS, Boor PPC, Pieterman RFA, et al. Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma. JHEP Rep. 2022;4(11):100576. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100576.","journal-title":"JHEP Rep"},{"issue":"7","key":"527_CR273","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.7150\/ijbs.70691","volume":"18","author":"H Jin","year":"2022","unstructured":"Jin H, Qin S, He J, Xiao J, Li Q, Mao Y, et al. New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials. Int J Biol Sci. 2022;18(7):2775\u201394. https:\/\/doi.org\/10.7150\/ijbs.70691.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"527_CR274","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1001\/jamaoncol.2023.4003","volume":"9","author":"S Qin","year":"2023","unstructured":"Qin S, Kudo M, Meyer T, Bai Y, Guo Y, Meng Z, et al. Tislelizumab vs sorafenib as first-line treatment for unresectable hepatocellular carcinoma: a phase 3 randomized clinical trial. JAMA Oncol. 2023;9(12):1651\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2023.4003.","journal-title":"JAMA Oncol"},{"issue":"5","key":"527_CR275","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1159\/000537966","volume":"13","author":"RS Finn","year":"2024","unstructured":"Finn RS, Kudo M, Barnes G, Meyer T, Boisserie F, Abdrashitov R, et al. Tislelizumab versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: impact on health-related quality of life in RATIONALE-301 study. Liver Cancer. 2024;13(5):548\u201360. https:\/\/doi.org\/10.1159\/000537966.","journal-title":"Liver Cancer"},{"issue":"10408","key":"527_CR276","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S0140-6736(23)00961-3","volume":"402","author":"S Qin","year":"2023","unstructured":"Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, et al. Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study. Lancet. 2023;402(10408):1133\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(23)00961-3.","journal-title":"Lancet"},{"issue":"4","key":"527_CR277","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/hep4.1854","volume":"6","author":"TS Andrews","year":"2022","unstructured":"Andrews TS, Atif J, Liu JC, Perciani CT, Ma XZ, Thoeni C, et al. Single-cell, single-nucleus, and spatial RNA sequencing of the human liver identifies cholangiocyte and mesenchymal heterogeneity. Hepatol Commun. 2022;6(4):821\u201340. https:\/\/doi.org\/10.1002\/hep4.1854.","journal-title":"Hepatol Commun"},{"issue":"1","key":"527_CR278","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1038\/s41467-024-49236-7","volume":"15","author":"A Brazovskaja","year":"2024","unstructured":"Brazovskaja A, Gomes T, Holtackers R, Wahle P, K\u00f6rner C, He Z, et al. Cell atlas of the regenerating human liver after portal vein embolization. Nat Commun. 2024;15(1):5827. https:\/\/doi.org\/10.1038\/s41467-024-49236-7.","journal-title":"Nat Commun"},{"key":"527_CR279","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1038\/s41467-025-61346-4","volume":"16","author":"D Restagno","year":"2025","unstructured":"Restagno D, Saraswat M, Aziz PV, Smith K, Roberts AJ, Hintze J, et al. Mrc1 (MMR, CD206) controls the blood proteome in reducing inflammation, age-associated organ dysfunction and mortality in sepsis. Nat Commun. 2025;16:6267. https:\/\/doi.org\/10.1038\/s41467-025-61346-4.","journal-title":"Nat Commun"},{"key":"527_CR280","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12964-026-02997-8","volume":"24","author":"AS Al-Mughalles","year":"2026","unstructured":"Al-Mughalles AS, Ma J, Ma H, Zhang C, Xiao H, Ma X, et al. Liver sinusoidal endothelial cell fenestrations in metabolic liver disease: from molecular mechanisms to therapeutic perspectives. Cell Commun Signal. 2026;24:351. https:\/\/doi.org\/10.1186\/s12964-026-02997-8.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"527_CR281","doi-asserted-by":"publisher","first-page":"G757","DOI":"10.1152\/ajpgi.00017.2004","volume":"287","author":"LD DeLeve","year":"2004","unstructured":"DeLeve LD, Wang X, Hu L, McCuskey MK, McCuskey RS. Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation. Am J Physiol Gastrointest Liver Physiol. 2004;287(4):G757\u201363. https:\/\/doi.org\/10.1152\/ajpgi.00017.2004.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"527_CR282","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2026.114864","volume":"394","author":"LF Zhang","year":"2026","unstructured":"Zhang LF, Ru JW, Liang SQ, Zhang MM, Zhang CY, Liu JQ, et al. Nanotherapy targeting liver sinusoidal endothelial cells in liver fibrosis. J Control Release. 2026;394:114864. https:\/\/doi.org\/10.1016\/j.jconrel.2026.114864.","journal-title":"J Control Release"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00527-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00527-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00527-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:02:20Z","timestamp":1786939340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00527-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":282,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00527-z","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"139"}}